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ABSTRACT 
 
 
THE ROLE OF ANTIMICROBIAL COMPOUNDS IN THE LIFE CYCLE OF THE 
SYMBIOTIC BACTERIUM, XENORHABDUS NEMATOPHILA 
 
by 
Swati Singh 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Steven A. Forst, Ph.D. 
 
The bacterium Xenorhabdus nematophila maintains a mutualistic relationship with the 
entomopathogenic nematode Steinernema carpocapsae and is also pathogenic towards 
insect larvae. X. nematophila possesses a large number of gene clusters potentially 
involved in antimicrobial production. Several antibiotics, including xenocoumacin (Xcn) 
produced at high levels in broth cultures, have been characterized. In this study I 
established that during nematode invasion of the insect body cavity (hemocoel) gut 
microbiota enter the hemocoel representing potential competitors for X. nematophila. As 
infection progressed some transient species, such as Staphylococcus saprophyticus 
disappeared early in infection, while other persistent species such as Enterococcus 
faecalis proliferated. S. saprophyticus was found to be highly sensitive towards X. 
nematophila antibiotics and E. faecalis was more resistant. S. saprophyticus was 
eliminated when co-injected with X. nematophila into the insect host, Manduca sexta.  In 
contrast, E. faecalis proliferated when co-injected with X. nematophila. The induction of 
transcripts for cecropin, an insect antimicrobial peptide, by E. faecalis was suppressed by 
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the presence of X. nematophila suggesting that E. faecalis proliferation was due in part to 
a combination of immune suppression and relatively high antibiotic resistance. Injection 
of E. faecalis into M. sexta caused mortality suggesting that E. faecalis may contribute to, 
but is not required for, virulence in an insect infected with X. nematophila. The role of 
antibiotics in interspecies competition was assessed using various antibiotic-deficient 
strains of X. nematophila co-inoculated in LB broth with either S. saprophyticus or E. 
faecalis. Antibiotics are produced at high levels in LB broth. During the course of this 
study I discovered a new non-ribosomal peptide synthetase (NRPS) cluster (cluster F) 
that produced antibiotic activity. The elimination of S. saprophyticus required Xcn but 
not compound F. In contrast, elimination of E. faecalis was not dependent on either Xcn 
or compound F. When competitions were carried out in a more biologically relevant 
medium (Grace’s medium) based on lepidopteran insect hemolymph, both the 
competitors grew better than X. nematophila due to lower production of antibiotics in 
Grace’s medium and faster growth rate of the competitors. S. saprophyticus was 
eliminated when inoculated into growing cultures of either the xcn or F strains but grew 
in the presence of a strain (ngrA) completely devoid of antibiotic activity suggesting that 
antibiotics other than Xcn and compound F were required to eliminate the competitor. In 
contrast, E. faecalis was not eliminated in competition with any of the X. nematophila 
strains consistent with its relatively high antibiotic resistance. S. saprophyticus was 
eliminated when co-injected into M. sexta with either the xcn or ngrA strain while growth 
of E. faecalis was facilitated by co-inoculation with both of the mutant strains. Finally, 
when nematodes carrying the ngrA strain were used for natural infection of M. sexta, 
nematode reproduction was significantly reduced suggesting that NRPS-derived 
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compounds may function as developmental signals. Together, these findings establish the 
competitors for X. nematophila and the role of antimicrobials in differential competition 
and nematode reproduction. 
 
 
  
v 
 
TABLE OF CONTENTS 
 
Chapter One: Background and Significance: Antimicrobial Compounds and the Life 
Cycle of Xenorhabdus nematophila ..............................................................1 
1.0 Introduction ........................................................................................................2 
1.1. Challenges faced by X. nematophila in the insect host .....................................5 
1.1.1. Insect immune response .....................................................................5 
1.1.2. Microbial competitors in the infected insect hemolymph..................7 
1.2. Antimicrobial compounds produced by X. nematophila ..................................8 
1.2.1. Small molecule antimicrobials ...........................................................8 
1.2.2. Phage-tail bacteriocins and xenocin.................................................13 
1.3. Diverse functions of small molecule antimicrobial compounds .....................14 
1.4. Dissertation objectives ....................................................................................17 
1.5. References .......................................................................................................19 
Chapter Two: Microbial Population Dynamics in the Hemolymph of Manduca sexta 
                       Infected with Xenorhabdus nematophila and the Entomopathogenic   
Nematode, Steinernema carpocapsae ........................................................24 
2.0. Introduction .....................................................................................................25 
 
vi 
 
2.1. Materials and Methods ....................................................................................28 
2.1.1. Bacterial strains and growth conditions ...........................................28 
2.1.2. Sources, treatments and rearing of Manduca sexta larvae ...............28 
2.1.3. Gut dissections and isolation of gut microbes .................................29 
2.1.4. Natural infections, isolation of insect hemolymph and determination 
of microbial composition ...........................................................................30 
2.1.5. Antibiotic overlay assay ...................................................................31 
2.1.6. In vivo competitions .........................................................................32 
2.1.7. Immunosuppression by X. nematophila in the presence of natural 
competitors derived from M. sexta gut microbiota ....................................32 
2.1.8. Virulence comparison of gut and human OG1RF clinical strains of 
E. faecalis ...................................................................................................33 
2.1.9. GenBank accession numbers ...........................................................34 
2.2. Results .............................................................................................................34 
2.2.1. Translocation of gut microbiota to the hemolymph during natural 
infection .....................................................................................................34 
2.2.2. Microbial population dynamics in hemolymph of M. sexta infected 
with S. carpocapsae IJs..............................................................................38 
 
vii 
 
2.2.3. Sensitivity of competitors to X. nematophila antibiotics .................43 
2.2.4. In vivo competition in M. sexta ........................................................43 
2.2.5. Induction of antimicrobial peptide transcripts by E. faecalis is 
suppressed by X. nematophila....................................................................51 
2.2.6. E. faecalis isolated from the gut is pathogenic towards M. sexta ....53 
2.3. Discussion .......................................................................................................55 
2.4 References ........................................................................................................59 
Chapter Three: Differential Role of Antibiotics in the Life Cycle of Xenorhabdus 
nematophila ..............................................................................................63 
3.0. Introduction .....................................................................................................64 
3.1. Materials and Methods ....................................................................................70 
3.1.1. Bacterial strains and growth conditions ...........................................70 
3.1.2. Construction of the NRPS and ngrA mutant strains ........................72 
3.1.3. Antibiotic overlay assay ...................................................................73 
3.1.4. In vitro competitions in LB and Grace’s..........................................73 
3.1.5. In vitro competitions in LB with pre-incubated X. nematophila .....75 
3.1.6. Antibiotic activity in cell-free supernatants from LB and Grace’s 
cultures .......................................................................................................75 
viii 
 
3.1.7. Sources, treatments and rearing of Manduca sexta larvae ...............76 
3.1.8. In vivo competitions .........................................................................76 
3.1.9. Nematode reproduction ....................................................................77 
3.2. Results .............................................................................................................78 
3.2.1. Analysis of NRPS gene clusters for antibiotic activity ....................78 
3.2.2. Competition of S. saprophyticus and E. faecalis with  
X. nematophila ...........................................................................................80 
3.2.3. Comparison of antibiotic activity in LB broth and Grace’s medium 
culture supernatants ...................................................................................86 
3.2.4. Competition in Grace’s medium pre-inocubated with X. 
nematophila strains ....................................................................................90 
3.2.5. Competition in the insect host, Manduca sexta ...............................94 
3.2.6. Natural infection and nematode reproduction in M. sexta ...............94 
3.3. Discussion .......................................................................................................99 
3.4 References ......................................................................................................105 
Appendix: Supplemental Figures: Structures of Compounds Produced by X. 
nematophila and Schematic Illustrations of NRPSs  ...........................................109 
Curriculum Vitae .................................................................................................114  
ix 
 
LIST OF FIGURES 
FIG. 1.1. Schematic diagram of the X. nematophila – S. carpocapsae life cycle 
highlighting the pathogenic phase .......................................................................3 
FIG. 2.1. Microbial population dynamics in hemolymph of M. sexta naturally infected 
with S. carpocapsae ..........................................................................................39 
FIG. 2.2. Microbial population dynamics in hemolymph of M. sexta naturally infected 
with S. carpocapsae ..........................................................................................40 
FIG. 2.3. Microbial population dynamics in hemolymph of M. sexta naturally infected 
with S. carpocapsae ..........................................................................................41 
FIG. 2.4. Antibiotic activity of X. nematophila against the microbes present in the insect 
hemolymph ........................................................................................................44 
FIG. 2.5. In vivo growth of isolates in M. sexta hemocoel after injection .........................45 
FIG. 2.6. In vivo growth after 1:1 co-injections of X. nematophila with S. saprophyticus 
or E. faecalis into M. sexta..................................................................................47 
FIG. 2.7. In vivo growth after 1:1 co-injection of E. faecalis and S. saprophyticus into M. 
sexta ....................................................................................................................48 
FIG. 2.8. Antibiotic overlay assay testing mutual activity of E. faecalis and S. 
saprophyticus antibiotic activity against each other. .........................................49 
FIG. 2.9. In vivo competition between X. nematophila and E. faecalis in M. sexta co-
injected at varying ratios .....................................................................................50 
 
x 
 
FIG. 2.10. Relative cecropin transcript levels in insects injected with E. faecalis and S. 
saprophyticus alone, and co-injected with E. faecalis and X. nematophila .....52 
FIG. 2.11. Comparison of the virulence of E. faecalis (gut isolate), E. faecalis (OG1RF), 
and X. nematophila towards M. sexta ..............................................................54 
FIG. 3.1. NRPS gene clusters in the genome of X. nematophila .......................................67 
FIG. 3.2. Antibiotic overlay assay demonstrating activity of xenocoumacin against 
M.luteus, E. faecalis and S. saprophyticus; of compound F against M. luteus 
and S. saprophyticus; and complete lack of activity of the ngrA mutant ..........79 
FIG. 3.3. Antibiotic overlay assay demonstrating antibiotic activity of compound C and 
lack of activity of compounds A, B, D and E ....................................................81 
FIG. 3.4. In vitro competition between X. nematophila mutant strains and S. 
saprophyticus in LB ............................................................................................83 
FIG. 3.5. In vitro competition between X. nematophila mutant strains and E. faecalis in 
LB .......................................................................................................................84 
FIG. 3.6. In vitro competition of wild-type X. nematophila with S. saprophyticus (A) or E. 
faecalis (B) in Grace’s .......................................................................................85 
FIG. 3.7. Growth rates of X. nematophila in LB broth and Grace’s medium....................91 
FIG. 3.8. In vivo growth after 1:1 co-injections of X. nematophila ΔxcnKL strain with S. 
saprophyticus or E. faecalis into M. sexta .........................................................95 
FIG. 3.9. In vivo growth after 1:1 co-injections of X. nematophila ngrA strain with S. 
saprophyticus or E. faecalis into M. sexta .........................................................96 
xi 
 
FIG. 3.10. In vivo nematode reproduction using S. carpocapsae carrying X. nematophila 
wild-type and ngrA strains after natural infection of M. sexta ........................98 
FIG. A.1. Known antimicrobial compounds produced by X. nematophila .....................110 
FIG. A.2. Other small molecules produced by X. nematophila with antibiotic activity ..111 
FIG. A.3. Reactions catalyzed by NRPS domains ...........................................................112 
FIG. A.4. Phosphopantetheinylation by the enzyme PPTase which is a product of the 
ngrA gene in X. nematophila .........................................................................113 
 
 
  
xii 
 
LIST OF TABLES 
TABLE 1. Known antimicrobial compounds produced by X. nematophila ......................10 
TABLE 2. Published diversity of gut microbiota of Manduca sexta ................................35 
 TABLE 3. Transfer of microbiota from the gut to the hemolymph during natural 
infection of Manduca sexta ............................................................................37 
 TABLE 4. NRPS and PKS clusters in X. nematophila with unidentified activity ...........68 
 TABLE 5. Bacterial strains and plasmids used in this study ............................................71 
 TABLE 6. Primers used in this study ...............................................................................74 
 TABLE 7. Growth comparison between X. nematophila and S. saprophyticus in Grace’s 
medium ...........................................................................................................87 
 TABLE 8. Growth comparison between X. nematophila and E. faecalis in Grace’s 
medium ...........................................................................................................88 
TABLE 9. X. nematophila antibiotic activity in cell-free supernatants .............................89 
 TABLE 10. Competition of S. saprophyticus with pre-incubated X. nematophila in 
Grace’s medium ............................................................................................92 
 TABLE 11. Competition of E. faecalis with pre-incubated X. nematophila in Grace’s 
medium .........................................................................................................93 
 
 
 
 
xiii 
 
ACKNOWLEDGEMENTS 
I will always remember my journey as a Ph.D. student. I will cherish memories of 
these years, stories that I will like to retell. My stories will tell of successes, small joys, 
triumphs, laughter, with a sprinkling of unavoidable anxiety, hopelessness, and 
frustration. But my tales are not just mine, my experiences not mine alone. I will 
remember them because of people who have made them memorable. In these pages I will 
try my humble best, fumbling with words, stumbling to express my gratitude, to convey 
thanks to all the people who have made this journey possible. 
I can already think of a story, of how I came to be in this place, this lab. It was 
made possible due to my graduate mentor, Dr. Steven Forst. He knows the story, but 
what he may not have heard mentioned enough is my gratitude to him, because it cannot 
be expressed enough. He has been the best mentor I could ask for, a wonderful teacher 
who guided me, encouraged me, and kindled in me the spark of ideas with numerous 
helpful discussions. He is incredibly calm, patient, a brilliant scientist, who continues to 
harbor the excitement and enthusiasm for science that is infectious, and helped me see 
patterns, stories, and light, when I could not see them. On a more personal note, I would 
like to thank him for being a father figure to me.  
I am deeply grateful to the members of my graduate committee, Dr. Charles 
Wimpee, Dr. Mark McBride, Dr. Gyaneshwar Prasad and Dr. Daniel Sem. Thank you for 
your advice, comments, observations and time, all of which made possible the successful 
completion of my graduate dissertation.  
In the years working towards my Ph.D. the network of people who have made my 
stay a wonderful experience are the members, past and present, of the Forst lab. My 
xiv 
 
heartfelt thanks go out to Dr. Ransome van der Hoeven and Dr. Dongjin Park, for being 
my teachers and friends. I learned a lot from them and they helped mould the initial phase 
of my graduate career. I would like to thank Jordan Reese, my friend, with whom I 
worked on many experiments. I thank other members of the lab, Nydia, Kristin, Mary, 
Kishore, John, for being really great, friendly, helpful people, who made the lab a great 
place to be. Thanks are also in order to Thomy, Andrea, David, Matt and Emmanuel, 
talented undergraduate students, who assisted me in my work. Mentoring them was an 
enjoyable experience. 
I am grateful to the faculty and staff of the Department of Biological Sciences. 
My special thanks go to Dr. Jane Witten for providing insects for my work and to Dr. 
Sergei Kuchin for help with the statistical analysis. I would also like to thank Ching-Liu 
Wu and Thomas Schuck for always being ready to help on numerous occasions.  
I would like to thank our collaborators, Dr. Heidi Goodrich-Blair and Ángel 
Casanova-Torres at the University of Wiscon-Madison for contributing wonderful data to 
my work. 
And finally, my stories will not be complete without the endless support and 
unconditional love of my families. Words will always be inadequate to express the 
entirety of my gratitude and love for my parents, who made this possible. I have always 
wanted this, I will admit unhesitatingly, more for you than for me. This success is for 
you. Thanks also to my brother, and my wonderful in-laws, for all your love and 
understanding. And my deepest thanks go to my husband, Joe, who has supported me in 
more ways than he realizes, for his continued faith in me, and for his enduring love.  
 
1         
 
 
Chapter One 
 
 
Background and Significance: Antimicrobial Compounds and the Life 
Cycle of Xenorhabdus nematophila  
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1.0 Introduction 
Bacteria exist in multispecies populations in which competition for resources and 
space drive community dynamics and evolutionary processes. Microbial communities 
that associate with animals and plants are widespread in nature. Pathogens that infect 
animal hosts confront a dual challenge of competing with other microbes in the 
environment and evading or suppressing activated immune responses of the host. In 
defensive mutualistic relationships the ability to produce antimicrobials to eliminate 
competitors and compounds to suppress the immune response can improve the fitness of 
a symbiotic partner. While competition under laboratory conditions has been extensively 
studied, much less is known about the competitive interactions in a host organism. The 
tripartite symbiosis involving the mutualistic-pathogenic bacterium Xenorhabdus 
nematophila, entomopathogenic nematode Steinernema carpocapsae, and susceptible 
insect hosts provides an excellent tractable model to study microbial competition and 
immune suppression in a natural biological environment.  
In the dual-mode life cycle of X. nematophila the bacterium-nematode symbiont 
pair initiates infection of the insect host (FIG. 1.1). The bacterium X. nematophila 
colonizes a specialized region of the anterior intestine (receptacle) of the non-feeding 
juvenile stage of the nematode called the infective juvenile (IJ) that forages in the soil 
searching for susceptible insect hosts (1-3).  The IJ invades insect larvae through natural 
openings such as the mouth or anus, punctures the midgut to enter the hemocoel (body 
cavity) and expels X. nematophila from the receptacle via the anus into the hemolymph 
where the bacteria transition to their pathogenic stage (2).  
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FIG. 1.1. Schematic diagram of the X. nematophila – S. carpocapsae life cycle 
highlighting the pathogenic phase  
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Once in the hemocoel X. nematophila functions as a pathogen. Part of being a 
successful insect pathogen is the ability to suppress the insect innate immune response, 
and another is host-killing, brought about by  the insect toxins, cytotoxins, and 
hemolysins that Xenorhabdus secretes (4).  Following insect death, bioconversion of the 
insect cadaver occurs due to exoenzymes produced by X. nematophila and the diverse 
antimicrobial compounds that it produces are believed to play a role in protection of the 
nutrient resources. The bacteria multiply using the now abundant nutrients and the 
nematodes feed on the bacteria and nutrients from the insect cadaver as they develop and 
reproduce. After 2-3 rounds of sexual reproduction, when nutrient sources are depleted, 
the second juvenile form develops into the specialized pre-IJ stage that is colonized by X. 
nematophila. Once colonized, the IJ leaves the cadaver in search of another insect host.  
During this pathogenic phase, translocation of gut microbes into the hemocoel 
during nematode invasion, coupled with suppression of insect host immune response by 
X. nematophila may facilitate the growth of competitors in the insect hemocoel.  The 
proliferation of gut-derived microbes in the hemocoel could in turn antagonize the 
reproduction of S. carpocapsae and suppress the growth of X. nematophila in the 
hemolymph.  X. nematophila produces a plethora of antimicrobial compounds that are 
believed to participate in controlling competitor growth. Among the various 
antimicrobials produced by bacteria and fungi, three broad classes have been defined: 
small molecule antibiotics, peptide and protein bacteriocins, and contractile phage-tail 
bacteriocins. X. nematophila is unique among bacteria in producing antimicrobial 
compounds belonging to all three classes. Besides producing numerous small molecule 
antimicrobial compounds, X. nematophila produces phage-tail structures called 
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xenorhabdicins that bind to and kill related Xenorhabdus species and strains as well as 
the sister taxon Photorhabdus luminescens (5, 6).  Xenorhabdicins provide a competitive 
advantage when an insect is co-invaded by more than one nematode species (6). X. 
nematophila also produces a protein bacteriocin called xenocin that displays broad 
antibiotic activity (7).  
Although it has been assumed that antimicrobials are involved in interspecies 
competition and enhance the proliferation of X. nematophila and development of its 
nematode partner, such roles in the host have never been conclusively demonstrated. 
Most of the antimicrobial compounds have been studied in in vitro conditions which are 
completely different from the bacterium’s actual natural environment. It is also possible 
that some of the compounds that exhibit in vitro antibiotic activity may have other 
functions in the host environment.  
 
1.1. Challenges faced by X. nematophila in the insect host 
1.1.1. Insect immune response 
When S. carpocapsae invades the hemocoel microbiota from the insect gut 
translocate into the hemocoel and as yet unidentified signals induce pharyngeal pumping 
that expels X. nematophila into the hemolymph (2). Foreign microbes in the hemocoel 
are recognized by pattern recognition proteins (PRP) such as hemolin, peptidoglycan 
recognition protein (PGRP), and immulectins (8). PRPs in the hemolymph bind 
conserved microbial-associated molecular pattern (MAMP) motifs on the surfaces of the 
foreign microbes. After the appropriate interactions between the PRPs and MAMPs, the 
insect innate immune response is activated. An example of a PRP is hemolin that binds 
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bacterial surfaces and causes protein complexes to form (9). Once activated, the immune 
response of insects consists of both cellular and humoral pathways. The cellular response 
involves activation of hemocytes that entrap microbial invaders in cell aggregates 
referred to as nodules. Humoral immune responses include stimulation of phospholipase 
A2 (PLA2) activity that releases arachidonic acid from membrane phospholipids 
resulting in the production of eicosanoids that activate hemocytes and induce expression 
of antimicrobial peptides (AMPs) such as cecropin (10, 11). Cecropin is a bacteria-
inducible antimicrobial peptide that attacks bacterial cell membranes leading to cell lysis 
(11). A central response of the innate immune system is the conversion of 
prophenoloxidase (ProPO) to the active phenoloxidase (PO) involved in quinone 
synthesis and formation of melanin that binds to the microbial cell surface functioning as 
an opsonin.  
X. nematophila produces several compounds that suppress different components 
of the insect innate immune response. For example, the tyrosine-derived cell surface 
molecules (rhabduscin) that directly inhibit PO activity (12) and the monoterpenoid 
compound benzylideneacetone (13) that inhibits PLA2 activity, reduces AMP synthesis 
and blocks PO  activity (10, 14, 15). Eight different secondary metabolites, including 
benzylideneacetone, that inhibit phenoloxidase and PLA2, were shown to be produced 
sequentially in broth cultures suggesting they act cooperatively to inhibit different stages 
of the immune response (16). 
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1.1.2. Microbial competitors in the infected insect hemolymph 
It would be logical for the most encountered competing microorganisms in the 
insect hemocoel to be the insect’s own gut microbiota. It has been assumed that microbes 
translocate from the insect gut into the hemocoel during nematode invasion. However, 
characterization of gut microbiota and especially monitoring its movement into the 
hemocoel during infection had not been reported.  
Entomopathogenic nematodes have been shown to infect several Orders of 
insects, including Lepidoptera, Diptera, Coleoptera, Orthoptera, and Hymenoptera (17, 
18). Different host organisms will harbor entirely different consortia of commensal 
microorganisms, indeed, variations have even been found among the gut microbiota of 
the same type of insects upon varying their diet. The insect gut microbiota represents the 
largest reserve of competitors to X. nematophila if they gain access to the insect 
hemocoel during a natural infection as the nematode breaches the intestinal barrier.   
The model insects that have been most used to study the life cycle of 
entomopathogenic nematodes are the three lepidopterans, the tobacco hornworm 
(Manduca sexta), the wax worm (Galleria mellonella), and the common cutworm 
(Spodoptera littoralis).  In Galleria mellonella, Enterococcus sp. were the most dominant 
bacteria isolated in three studies (19-21). In another analysis which identified only Gram- 
negative bacteria, Salmonella, Pasteurella and Xanthomonas were isolated from the gut 
of G. mellonella (22). Interestingly, Enteroroccus sp. was also found in the gut of M. 
sexta when raised on the diet of tobacco leaves (23). When raised on a standard lab diet 
containing antibiotics, the M. sexta gut isolates included predominantly the Gram-
positive bacteria, Paenibacillus and Bacillus, and the Gram-negative bacterium, 
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Methylobacterium.  In contrast, when raised on standard antibiotic-free diet, the 
microbiota of M. sexta contained predominantly Gram-positive Staphylococcus and 
Pediococcus sp. and no Gram-negative bacteria (24).  The microbiota of Spodoptera has 
not yet been analyzed. These findings reveal the enormous microbial diversity arising 
from the insect gut microbiota, which varies depending on the insects and even among 
insects, on the diet used. 
 Other sources of potential competitors are the non-symbiotic bacteria that might 
be carried between the cuticle and outer sheath of the IJs. Yet another type of competitive 
interactions that are feasible is competition between different Xenorhabdus species or 
between Xenorhabdus and Photorhabdus, both nematode-associated entomopathogens. 
This can occur when the insect host is co-invaded by two or more different Steinernema 
species carrying different Xenorhabdus species, or Heterorhabditis species that harbor 
Photorhabdus.  In such cases, the effective antimicrobial defenses would include those 
that can target closely-related organisms, and include proteinaceous and phage-tail 
bacteriocins.  
 
1.2. Antimicrobial compounds produced by X. nematophila  
1.2.1. Small molecule antimicrobials  
Most small molecule antimicrobial compounds are usually synthesized by 
complex multi-enzyme systems consisting of non-ribosomal peptide synthetases (NRPS) 
and/or polyketide synthetases (PKS). NRPSs are modular enzymes composed of one or 
more adenylation (A) domains that bind a specific amino acid, a transfer or peptidyl 
carrier protein (T/PCP) domain that shuttles the activated amino acid, and the 
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condensation (C) domain that accepts the activated amino acid and catalyzes peptide 
bond formation (25). Five different classes of compounds synthesized by NRPS or 
NRPS-PKS biosynthetic clusters have been characterized to date (TABLE 1). The 
compounds have been isolated from X. nematophila cultures grown to stationary phase in 
nutrient-rich, complex media. Their activities were tested against indicator laboratory 
strains or clinical strains but not against biologically relevant microbial competitors. 
Three of the classes (xenocoumacin, xenematide and PAX peptides) have antibacterial 
and/or antifungal activity while the activities of the remaining two compound classes 
(rhabdopeptide and xenortide) remain unclear (FIG. A.1).  
           Xenocoumacins, the first antimicrobials isolated from X. nematophila, are water-
soluble benzopyran-1-one compounds (26). X. nematophila produces two forms of 
xenocoumacin, Xcn1 and Xcn2.  These compounds are structurally and 
pharmacologically similar to the amicoumacins produced by Bacillus pumilus.  Both 
Xcn1 and Xcn2 are active against low G+C Gram-positive bacteria and some E. coli 
strains but are not active against other Gram-negative bacteria tested. Xcn1 is active 
against several fungal species but was inactive towards Candida albicans. Xcn2 does not 
display antifungal activity.  Structural analysis predicted that leucine and arginine 
residues and several acetate units were utilized for synthesis of Xcn1 (26) . 
 The 14 gene cluster that encodes enzymes required for production of Xcn1 and 
Xcn2 and the biosynthetic pathway have been characterized (27, 28). The xcn 
biosynthetic cluster contains two NRPS genes (xcnA, xcnK) and three PKS genes (xcnF, 
xcnH, xcnL). A mechanism to prevent self-toxicity to X. nematophila from Xcn has also  
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TABLE 1. Known antimicrobial compounds produced by X. nematophila 
      
Name Class Activity NRPS PKS References 
Xenocoumacin Benzopyran Antibacterial 2 3 McInerney, 1991 
  Antifungal   Park, 2009 
     Reimer, 2009 
      
Xenematide Cyclic Antibacterial 1 0 Lang, 2008 
 Non-polar    Crawford, 2011 
      
PAX peptides Lysine-rich Antifungal 3 0 Gualtieri, 2009 
 cyclolipopeptide Antibacterial   Fuchs, 2011 
      
Rhabdopeptide Linear Antiparasitic 4 0  
 Non-polar Cytotoxic   Reimer, 2013 
      
Xenortide Di-amino acid Unknown - - Lang, 2008 
 Non-polar     
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been described (27). The penultimate genes in the xcn cluster, xcnM and xcnN, encode 
enzymes that are involved in an unusual reaction in which the guanidinium group of 
arginine is removed resulting in a cyclic pyrolidine structure forming the less active Xcn2 
(28). Prolonged incubation of an xcnM mutant strain resulted in accumulation of Xcn1 
and a reduced viability possibly due to self-toxicity from high concentration of Xcn1 
(27).  
Studies with the wax worm, Galleria mellonella infected with X. nematophila 
suggested that Xcn1 and Xcn2 were produced in insecta. Water extracts of macerated G. 
mellonella cadavers infected with X. nematophila displayed antibiotic activity against 
Gram-positive species while the activity against Gram-negative species was more 
variable (29).  HPLC analysis identified the presence of Xcn1 and 2 in a ratio of 1:1 in 
these extracts. Antibiotic activity was not recovered by extraction of X. nematophila-
infected G. mellonella with organic solvents. 
Another antibacterial compound produced by X. nematophila is a cyclic 
depsipeptide (Thr-Trp-Trp-β-Ala) called xenematide that is active against some Gram-
positive and Gram-negative bacteria (30). It is produced by a stand-alone NRPS 
(XNC1_2713) that contains four adenylation modules (31).  
X. nematophila also produces a group of lysine-rich cyclolipopeptides called PAX 
(Peptide-Antimicrobials-Xenorhabdus) that have high activity against various human and 
plant fungal pathogens, lower activity against Gram-positive bacteria and minimal 
activity against Gram-negative bacteria (32). Thirteen different PAX compounds have 
been identified to date (33). The biosynthetic cluster that produces the PAX compounds 
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consists of three NRPS genes, the first of which contains one adenylation domain while 
the second and third NRPS genes contain three adenylation domains each.  
Linear, NRPS-derived peptides called rhabdopeptides were recently identified by 
an in vivo expression technology (IVET)  approach (34). The biosynthetic cluster for 
rhabdopeptides consists of three NRPS genes each containing one adenylation domain. 
Six different rhabdopeptides were isolated from broth cultures. Interestingly, 
rhabdopeptides were active against parasites such as Trypanosoma brucei and T. cruzi 
while their activity against bacteria and fungi was not reported. Rhabdopeptides were 
produced in G. mellonella infected with X. nematophila reaching optimal levels 10 days 
post-injection when the insect bioconversion or nematode reproduction stages are 
occurring.  
The fifth class of compounds are two dipeptides called xenortides (30). 
Xenortides were not active against bacterial and fungal indicator stains tested and did not 
possess cytotoxic activity.  
Four other NRPS and NRPS-PKS gene clusters have been identified in the 
genome of X. nematophila.  Three of the clusters contain only NRPS genes. These 
include XNC1_2299-30 (two NRPS genes), XNC1_2038-40 (three NRPS genes), and 
XNC1_2464-67 (four NRPS genes). In addition, a mixed hybrid cluster containing three 
NRPS genes (XNC1_1762-64) and two PKS genes (XNC_ 1756-57) has been identified. 
A stand-alone gene, XNC1_2022 (xtpS - NRPS with four adenylation domains), encodes 
xenotetrapeptide (35). Other than XNC1_2022, the compounds encoded by these clusters 
have not yet been identified.  
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Several small non-polar compounds possessing antibiotic activity but that have 
not yet been associated with any genes have been isolated from broth cultures of X. 
nematophila (FIG. A.2) (13, 36, 37).  Two related indole derived compounds isolated 
from stationary phase cultures were active against low G+C Gram-positive bacteria, 
members of the Enterobacteriaceae and Pseudomonas sp.  Nematophin, a novel indole-
type compound, was active against Bacillus and Staphylococcus sp. (38). Finally, 
benzylideneacetone that possesses immune suppression activity as described below was 
shown to be active against some species of Gram-negative plant pathogens (13).  At 
present, the modes of action of the numerous antimicrobial compounds produced by X. 
nematophila are not known.  
 
1.2.2. Phage-tail bacteriocins and xenocin 
Microbial competitors other than those derived from the insect gut can gain access 
to the hemocoel when an insect host is co-invaded by different species of 
entomopathogenic nematodes. Thus, competition can occur between different species and 
strains of Xenorhabdus and Photorhabdus in a host co-infected by their respective 
nematode partners (39-41). Small molecule antimicrobial compounds are generally not 
active against closely related species. Bacteria can produce phage tail-like structures that 
bind to and kill more closely related species. R-type bacteriocins are contractile phage tail 
structures that resemble the tail portion of defective bacteriophages. R-type bacteriocins 
have been extensively studied in P. aeruginosa where binding to the cell surface of 
sensitive related bacteria causes contraction of the tail sheath and the penetration of the 
tail tube through the outer membrane resulting in depolarization of the cytoplasmic 
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membrane and increased permeability of the cell envelope (42, 43). X. nematophila 
produces R-type bacteriocins referred to as xenorhabdicins (5, 6, 44, 45). Xenorhabdicin 
was shown to have variable activity against various Xenorhabdus and Photorhabdus 
strains, and also demonstrated intraspecies activity (6). 
Finally, X. nematophila produces a 64 kDa bacteriocin called xenocin that 
possesses endonuclease activity and is induced under Fe
3+
 depleted conditions that may 
exist in the insect hemolymph.  Xenocin was shown to be active against gut bacteria 
isolated from Helicoverpa amerigera (cotton boll warm) larvae (7) . The xenocin-
immunity protein complex is secreted through the flagella secretion system (46). In the 
extracellular environment xenocin is believed to dissociate from the immunity protein 
and enter target cells where it degrades cellular nucleic acids.  
 
1.3. Diverse functions of small molecule antimicrobial compounds 
The overall percentage of the X. nematophila genome dedicated to secondary 
metabolism is 7.5% as compared to 4.5% for Streptomyces coelicolor (47). It would 
appear that there is a strong selection for secondary metabolites that confer the ability to 
effectively compete against a broad spectrum of microbes that X. nematophila may 
encounter. However, the antimicrobial compounds were isolated from cultures of X. 
nematophila grown in nutrient-rich complex media and tested against laboratory and 
clinical strains in in vitro assays. Whether these compounds are produced in insects at 
sufficient levels to suppress growth of potential competitors remains to be determined.  It 
is possible that several of the compounds play a role in immune suppression, nematode 
development, biofilm formation or other processes yet to be identified.  
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The most intensely studied antimicrobials are the small molecule antibiotics that 
have been exploited for their usefulness as therapeutics and additives in animal feed. 
These secondary metabolites are usually most active against distantly related species but 
may also be active against more closely related species and strains. Antibiotic production 
has been studied mostly under laboratory culture conditions in which antibiotics can 
reach high levels. Furthermore, the levels needed for an antimicrobial effect may be 
higher than the concentration of compound produced under natural biological conditions 
(48-52) Thus, compounds characterized as an antimicrobial under assay conditions may 
in fact have other functions, such as signaling molecules, in a natural biological 
environment.  
A large number of antimicrobial compounds are derived from Streptomyces 
species. A well studied example of a role for antimicrobial compounds in nature is a 
Streptomyces species (S4) involved in the mutualism between leaf-cutting attine ants and 
fungus cultivated by them for food (53). The fungal garden can be invaded by a co-
evolved fungal pathogen, Escovopsis sp. Streptomyces S4 colonizes a specialized 
structure on the cuticle of the ant and helps to protect the food source. In broth cultures 
Streptomyces S4 produces two antifungal compounds, candicidin and antimycin, that are 
active against Escovopsis. It was recently shown that a mutant strain deficient in both of 
these antifungal compounds was still able to inhibit growth of Escovopsis suggesting that 
the ant-associated Streptomyces is able to produce other antifungal compounds. The 
genome of the Streptomyces species was shown to contain several unassigned NRPS and 
PKS biosynthetic clusters that may produce antimicrobials. Whether antifungal 
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compounds are produced at high enough levels in nature to protect the fungal gardens 
remains to be determined.  
 Cumulative data supports the idea that in nature most antimicrobial compounds 
are produced at sub-inhibitory concentrations (SIC). The concentrations of antimicrobials 
produced in soil environments are unlikely to reach levels seen under broth culture 
conditions (54). Numerous studies have shown that antimicrobials can cause a differential 
response depending on concentration. This phenomenon is referred to as hormesis. For 
example, using promoter-lux reporter libraries of Salmonella typhimurium as many as 5% 
of the promoters were modulated by exposure to SIC of either erythromycin or rifampicin 
(49). The genes affected encoded diverse functions such as transport, virulence and DNA 
repair. Furthermore, the so-called antibiotics may have different physiological and 
ecological effects. Phenazines produced by Pseudomonas aeruginosa not only have 
antibiotic activity but also are involved in the transfer of electrons when oxygen is 
unavailable (55). Likewise, isopropylstilbene, a major antibiotic compound produced by 
Photorhabdus luminescens, also inhibits insect immune responses and serves as a 
developmental signal for the nematode partner, Heterorhabditis bacteriophora (56, 57).  
Finally, a large number of clinically relevant antibiotics induce biofilm formation in a 
variety of bacteria exposed to SIC of the antibiotic (48). 
The antimicrobial activity of X. nematophila was discovered over 30 years ago (1, 
36). Since then numerous antimicrobial compounds and biosynthetic gene clusters have 
been characterized. While it has been assumed that these compounds play a role in 
interspecies competition very little is known about the production of antimicrobials in the 
host and whether they function in other aspects of the life cycle of X. nematophila.  
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1.4. Dissertation objectives 
 X. nematophila engages in a defensive mutualistic relationship with a nematode 
partner and functions as a pathogen in the insect host. During the infectious phase of its 
life cycle X. nematophila faces competition with microbes growing in the hemolymph 
and an activated insect immune response.  It has never been conclusively established that 
the actual biological competitors for X. nematophila are the insect gut microflora. In this 
study we explore the microbial population dynamics that occur in the infected host 
hemolymph, which will help shed light on the interactions of X. nematophila with its 
competitors, and whether these interactions involve secondary metabolite antimicrobials. 
Numerous antimicrobial compounds have been isolated from broth cultures of X. 
nematophila but their production and role in competition has never been studied in more 
biologically relevant media or host systems. Also, despite the large field of study of small 
molecule antibiotics by bacteria, our knowledge of whether they are produced in natural 
environments is limited. Their role as antimicrobial agents has also been tested only 
against lab strains and never biologically relevant competitors. Finally, secondary 
metabolites may serve as developmental signals for the nematode and function in as yet 
unidentified processes in the life cycle of X. nematophila. The goal of this study is to 
determine the microbial competitors to X. nematophila and the relative contributions of 
X. nematophila antimicrobials and insect immune response to the microbial population 
dynamics in the insect hemolymph. Using biologically relevant competitors, we 
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determine the effect of growth and assay conditions on antimicrobial determination, the 
differential competition tactics of X. nematophila against different competitors, and the 
role of an unidentified NRPS gene cluster.  By creating mutant strains deficient in 
antimicrobial production we suggest other possible functions of antimicrobial compounds 
in the life cycle of X. nematophila. 
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Chapter Two 
 
 
Microbial Population Dynamics in the Hemolymph of Manduca sexta 
Infected with Xenorhabdus nematophila and the Entomopathogenic 
Nematode, Steinernema carpocapsae 
 
The text of this chapter is a slightly modified version of the accepted paper: 
Singh S, Reese JM, Casanova-Torres ÁM, Goodrich-Blair H, Forst S. 2014. 
Microbial population dynamics in the hemolymph of Manduca sexta infected with 
Xenorhabdus nematophila and the entomopathogenic nematode, Steinernema 
carpocapsae. Appl. Environ. Microbiol. 80: In press. 
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2.0. Introduction 
Bacteria rarely exist in isolation and are usually found in multispecies populations 
in which competition for resources and space becomes a prime factor in driving 
community dynamics and evolutionary processes. For pathogens there exists a dual 
challenge of competing with other microbes in the environment and evading or 
suppressing activated immune responses. Competition under laboratory conditions has 
been extensively studied but much less is known about the competitive interactions in a 
host organism. The tripartite system involving the symbiotic-pathogenic bacterium 
Xenorhabdus nematophila, an entomopathogenic nematode and an insect host provides a 
tractable model to study microbial competition and immune suppression in a natural 
biological environment.  
Xenorhabdus nematophila exhibits a bimodal life cycle: it establishes a species-
specific mutualistic relationship with the entomopathogenic nematode Steinernema 
carpocapsae and launches a pathogenic attack on susceptible insect larvae (1-5). The 
infective juvenile (IJ) stage of the nematode invades insect larvae through natural 
openings such as the mouth or anus, punctures the midgut to enter the hemocoel (body 
cavity) and releases X. nematophila into the hemolymph (2). X. nematophila is not 
detected in the hemolymph 5 h post-invasion while by 12 h it colonizes the connective 
tissue surrounding the anterior midgut (6). In the hemocoel X. nematophila functions as a 
pathogen by suppressing the host immune system and secreting insect toxins, cytotoxins, 
and hemolysins that participate in killing the host (4).  
An initial step towards mounting an insect immune response is recognition of 
foreign microbes by pattern recognition proteins (PRP) such as hemolin, peptidoglycan 
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recognition protein (PGRP), and immulectins (7, 8) . PRPs bind conserved microbial-
associated molecular pattern (MAMP) motifs and initiate the immune response. The 
immune response comprises humoral and cellular pathways. Humoral immune responses 
include stimulation of phospholipase A2 (PLA2) activity that releases arachidonic acid 
from membrane phospholipids resulting in the production of eicosanoids that activate 
hemocytes and induce expression of antimicrobial peptide (AMP) genes (9). Cecropin is 
a bacteria-inducible AMP that disrupts bacterial cell membranes leading to cell lysis (10).  
Cellular immune responses use circulating hemocytes to bring about phagocytosis, 
aggregation, and encapsulation or nodulation (11). A central response of the innate 
immune system is the conversion of prophenoloxidase (ProPO) to the active 
phenoloxidase (PO) involved in quinone synthesis and formation of melanin that binds to 
the microbial cell surface functioning as an opsonin. X. nematophila produces several 
compounds that suppress aspects of the insect innate immune response. These include 
tyrosine-derived cell surface molecules (rhabduscin) that directly inhibit PO activity (12) 
and the monoterpenoid compound benzylideneacetone (13) that inhibits PLA2 activity, 
reduces AMP synthesis and blocks PO activity (9, 14). Interestingly, benzylideneacetone 
itself has antimicrobial activity (13).  
Suppression of insect host immunity may benefit X. nematophila but can also 
facilitate the growth of competitors in the insect hemocoel and it is therefore important to 
understand the broader microbial ecology of a X. nematophila-infected host. The tobacco 
hornworm, Manduca sexta, is a model insect commonly used to study X. nematophila 
pathogenicity and suppression of host immune responses (11).  The intestinal microbiota 
of M. sexta has been characterized in insects grown on different diets. In insects raised on 
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the natural diet of tobacco leaves Enterococcus spp. were the predominant species 
isolated from the gut(15). Enterococcus faecalis is a common gut microbe isolated from 
Lepidoptera (16) and several other orders of insects (17). Recently, it was shown that 
injection of a clinical strain of E. faecalis into the hemocoel of M. sexta caused insect 
death whereas when this strain was introduced into the gut it persisted without overt 
damage to the host. However, when E. faecalis-colonized insects were also fed the pore-
forming insecticidal Bt toxin, E. faecalis translocated into the hemocoel, causing insect 
immune response induction and death (18).  
Whereas X. nematophila produces diverse antimicrobial products in culture, the 
role they play in suppressing microbial competitors during infection remains poorly 
understood. Xenocoumacin (Xcn) is the major soluble antibiotic produced by X. 
nematophila in broth culture (19) and has been detected in the infected wax worm, 
Galleria mellonella (20).  Xcn1, the most active form of xenocoumacin, is produced at 
high levels and subsequently converted to the less active compound, Xcn2, to avoid self-
toxicity (21).  
 Very little is known about microbial competition during the early stages of 
invasion of the insect hemocoel by S. carpocapsae. In the present study we address 
several unanswered questions. Do microbes translocate from the insect gut into the 
hemolymph when the nematode invades the hemocoel?  Do gut microbes proliferate in 
the hemocoel? What are the population dynamics of competitors and X. nematophila 
during the early stage of infection? Do the competitors exhibit different sensitivities to 
the antimicrobial products of X. nematophila? 
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2.1. Materials and Methods 
2.1.1. Bacterial strains and growth conditions  
Xenorhabdus nematophila AN6/1 (phase 1, opaque colonies) was used as the 
wild-type strain. The E. faecalis human clinical strain OG1RF (22) was kindly provided 
by R. van der Hoeven. All bacteria used in this study were grown at 30°C in either Luria-
Bertani broth (LB) (23) or on LB agar plates (15 g/l
 
agar). After preparation, media were 
maintained in the dark. Strains grown overnight in LB broth (supplemented with 50 
µg/ml
 
ampicillin for X. nematophila) were subcultured (1:20) in 5 ml of fresh LB broth 
and growth was monitored by turbidity using a Klett-Summerson colorimeter or via 
optical density measurement at 600 nm (OD600). Final bacterial cultures were normalized 
using OD600 values. Grace’s insect culture medium (Gibco) was used to dilute cultures 
for insect injections and dilutional plating. 
 
2.1.2. Sources, treatments and rearing of Manduca sexta larvae  
Unless otherwise mentioned, M. sexta eggs were obtained from the insect colony 
at the University of Wisconsin – Milwaukee. Eggs were placed in clean plastic cups 
along with diet and incubated in an insect incubator with at 16:8 h light:dark photoperiod 
at room temperature. After hatching, larvae were moved to clean boxes and provided 
fresh diet. Boxes were cleaned daily and larvae were fed regularly. The fourth instar stage 
was used for all experiments. Commercial premixed diet (North Carolina State University 
Insectary, hence referred to as NCSU) without added antibiotics was the primary initial 
diet used, later prepared from individual ingredients. The diet was prepared according to 
supplier instructions (24). For some experiments, the commercially available Gypsy moth 
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diet (High Wheat Germ Diet, MP Biomedicals) prepared according to manufacturer’s 
instructions without added antibiotics was used. The diets were swabbed as well as 
homogenized then plated on LB agar plates and were shown to be devoid of microbial 
contamination. 
  
2.1.3. Gut dissections and isolation of gut microbes  
Fourth instar larvae anaesthetized on crushed ice for 15-20 min were surface 
sterilized by submerging in 70% cold ethanol. Dissecting implements were sterilized with 
ethanol and rubber gloves were worn during the procedure. The insect gut was exposed 
by dorsal incision and the dissected gut was placed in a sterile 1.5 ml tube containing 
between 200-500 µl of LB broth. The tissue was homogenized by grinding for 2 min 
using a Kontes pellet pestle micro grinder (Kimble Chase). Serial dilutions of the 
suspension were made in LB broth and plated on LB agar followed by incubation at 30°C 
for 48 h. The resulting colonies were categorized based on colony morphology, 
pigmentation and surface properties. Representative colonies of each type were patched 
to fresh plates and used for colony PCR to amplify 16S rRNA genes. Briefly, a small 
portion of the colony was resuspended in 3µl of nuclease-free water and boiled for 4 min. 
PCR amplification (25 µl final volume) was performed using the GoTaq® Green Master 
Mix kit (Promega) with 1 µl each of the 10µM universal 16S rRNA (bacterial) gene 
primers, 11F (5’-GTTTGATCCTGGCTCAG-3’) and 1512R (5’-
ACGGYTACCTTGTTACGACTT-), obtained from Integrated DNA Technologies, Inc.  
The PCR reaction was carried out for 30 s at 94
o
C, 30 s at 50
o
C and 2 min at 72
o
C for 30 
cycles. If direct colony PCR did not yield products, DNA extracted from overnight 
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cultures using the PurElute
™ 
Bacterial Genomic Kit (Edge BioSystems) was used in the 
PCR reaction. The PCR product was checked on an agarose gel and purified using the 
GENECLEAN
®
 Turbo kit (MP Biomedicals). Nucleotide sequence analysis was 
performed at the University of Chicago Cancer Research DNA Sequencing and 
Genotyping Facility. Trimmed sequences were used for BLASTN analysis for genus and 
species identification. For E. faecalis, S. saprophyticus, A. viridans, the sequences were 
at least 1000 nucleotides long and showed 99% identity along the entire length. In cases 
in which PCR amplification was unsuccessful, microscopic analysis was performed using 
a wet mount to identify large oval, nucleated and budding cells, characteristic of yeast. 
 
2.1.4. Natural infections, isolation of insect hemolymph and determination of 
microbial composition  
For natural infections, Steinernema carpocapsae infective juveniles (IJs) carrying 
wild-type X. nematophila were used. IJs washed and resuspended in sterile water were 
pipetted on wet filter paper lining the bottom of a plastic cup, at 200 IJs/insect. Several 
fourth instar larvae were added to each cup. To extract hemolymph at various times, 
larvae were anaesthetized on ice, placed in a bath of 70% ethanol for 30 s and air dried. A 
cut was made just below the last proleg and hemolymph was drained into sterile 1.5 ml 
tubes. Hemolymph was isolated from individual larvae and subsequently pooled for each 
time point. For culture-dependent determination of microbial composition of hemolymph, 
serial dilutions of the extracted hemolymph were plated in triplicate on LB agar plates 
that were incubated at 30°C for 48 h. Colonies were grouped according to colony 
morphology, color, shape and surface properties. At least three colonies of each type 
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were patched on LB agar and stored as glycerol stocks at -80°C. From the patch plates, 
colony PCR and BLASTN analysis was performed and used for species identification. 
Colonies in which 16S rRNA gene amplification was not successful were analyzed 
microscopically. Microscopic analysis using wet mounts revealed yeast cells. From the 
same hemolymph samples culture-independent analysis was carried out using 1 ml of 
pooled hemolymph that was centrifuged at 8000 r.p.m. at 4°C for 10 min. DNA was 
extracted from the bacterial pellet using the PurElute
™ 
Bacterial Genomic Kit (Edge 
BioSystems). Amplified 16S rRNA gene sequence was cloned into Escherichia coli using 
the pGEM
®
 - T Easy Vector kit (Promega). At least 20 positive clones were picked for 
each time point and colony PCR using SP6 and T7 primers was performed to amplify the 
cloned 16S rRNA genes. The PCR products were sequenced and characterized using 
BLASTN analysis as described above. The experiments were performed at least twice, 
with reproducible results. The experiments were performed at similar times of the day, 
with similar feeding cycles for the insects. 
 
2.1.5. Antibiotic overlay assay  
Subcultures of X. nematophila were grown to exponential phase and 6 µl samples 
of the culture were spotted on LB agar plates and incubated for 24 h. The bacteria were 
exposed to chloroform fumes for 30 min followed by air drying for 30 min. One milliliter 
of overnight culture of the indicator bacterial strain was added to 12 ml top agar (LB with 
0.7% agar) which was then poured to form a thin layer over the X. nematophila colonies 
(1, 25). The plates were incubated at 30°C for 48 h. Zones of inhibition were measured in 
millimeters. The overlay assays were performed four times, with nearly identical results. 
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2.1.6. In vivo competitions  
X. nematophila, E. faecalis and S. saprophyticus were subcultured in LB broth, 
grown to exponential phase, normalized and diluted in Grace’s medium. For the 
competition experiments three different ratios were used: a) 1:1 mixture of 10
4 
CFU/insect of the appropriate bacterial cultures, b) mixture consisting of 10
4 
CFU/insect 
X. nematophila and 10
5 
CFU/insect E. faecalis (1:10 ratio), and c) mixture consisting of 
10
5
 CFU/insect X. nematophila and 10
4
 CFU/insect E. faecalis (10:1 ratio). Fifty 
microliters of the mixtures were injected per insect using BD 1ml Sub-Q, 0.45 mm x 16 
mm syringes (Becton Dickinson Co.) mounted on a Stepper
™ 
Repetitive Dispensing 
Pipette (Dymax Corp.). Fourth instar M. sexta larvae were anaesthetized by placing on 
crushed ice for 15-20 min and the area around the horn was cleaned using 70% ethanol 
before each injection. Grace’s medium was injected as a negative control. The insects 
were placed in plastic cups and hemolymph was collected at designated time points, 
serially diluted and plated on LB agar as described above. Three to four larvae were used 
per time point and the experiment was performed at least twice, with reproducible results. 
Again, the experiments were performed at similar times of the day, with similar feeding 
cycles for the insects. 
 
2.1.7. Immunosuppression by X. nematophila in the presence of natural competitors 
derived from M. sexta gut microbiota  
 Two fifth instar larvae of M. sexta were injected with ~10
4 
CFU/insect of the 
following: X. nematophila, E. faecalis, S. saprophyticus, X. nematophila+E. faecalis, or 
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phosphate-buffered saline (PBS, as negative control). Insect fat body tissue (a major site 
for immune protein expression) was dissected 16 h post-injection, followed by total RNA 
extraction using TriZol reagent (Invitrogen). For reverse transcription, 5 µg of total RNA 
were treated with RQ1 RNase-free DNase I (Promega). Reverse transcription was 
performed using the Mg primer: 5’-CGGGCAGTGAGCGCAACGTTTTTTTTTTTT-3
′ (Integrated DNA Technologies) and AMV Reverse Transcriptase (Promega). cDNA 
was used as template for quantitative real time PCR (qRT-PCR). qRT-PCR was 
performed with Bullseye EvaGreen (MidSci) on a Bio-Rad iCycler.  Transcript levels of 
cecropin were measured and normalized against rpS3 using the following primers: 
cecropin-forward (5’- GGTCAAAGGATTCGTGACGC-3’) and cecropin-reverse  
(5’-TTTGATTGTCCTTTGAAAATGGCG-3’), rpS3-forward  
(5’-ACTTCTCAGGCAAGGAGTGC-3’) and rpS3-reverse (5’ 
GTCACCAGGATGTGGTCTGG-3’). Data were analyzed as previously described (26). 
Briefly, Ct values were normalized by calculating the ratio between the reference gene 
and the gene of interest and presented as a ratio between infected versus PBS injected 
larvae. Data were statistically analyzed using Mixed Effect ANOVA with a Tukey’s post-
hoc test for multiple comparisons on normalized Ct values (SAS Software). The 
experiment was performed four times. 
 
2.1.8. Virulence comparison of gut and human OG1RF clinical strains of E. faecalis  
Eggs obtained from Carolina Biological Supply Company raised on NCSU diet 
were used. Both strains of E. faecalis along with X. nematophila were grown overnight 
then subcultured in LB. Exponential phase cultures were normalized to obtain similar 
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CFUs and these cultures were diluted in Grace’s medium for injection. Fifty microliters 
of diluted culture were injected per larva in varying doses: 10
4 
CFU/insect for X. 
nematophila, and 10
4
, 10
5
, 10
6 
CFU/insect for both E. faecalis strains. Injections were 
performed as described above, using a BD 1ml Sub-Q, 0.45 mm x 16 mm syringe 
(Becton Dickinson Co.) mounted on a Stepper
™ 
Repetitive Dispensing Pipette (Dymax 
Corp.). Injected larvae were put in cups along with some food and moved to the insect 
incubator where they were observed for mortality for up to 69 h. Six larvae were used per 
condition and the experiment was performed twice with reproducible results. 
 
2.1.9. GenBank accession numbers 
 The GenBank accession numbers for 16S rRNA sequences are as follows: E. 
faecalis - KF709388, S. saprophyticus - KF709389, A. viridans - KF709390. 
 
 
2.2. Results  
2.2.1. Translocation of gut microbiota to the hemolymph during natural infection  
To address the question of whether or not insect gut microbiota translocate into the 
hemocoel during S. carpocapsae-X. nematophila infection, we first characterized the gut 
microbial community of our laboratory colony of M. sexta, since the gut microbiota of M. 
sexta can vary widely depending on the diet used to raise the insects (Table 3). In larvae  
 
 
 
3
5
 
 
TABLE 2. Published diversity of gut microbiota of Manduca sexta 
Insect Diet Antibiotics 
Added 
Egg Source Egg 
Treatment 
Major genera 
identified 
Method of 
identification  
Reference 
       
Natural diets       
Solanum dulcamara  
(Nightshade) 
None Lab colony None Bacillus,  
Serratia,  
Candida  
Culture-
dependent 
Toth-Prestia, 
1988 
       
Nicotiana tabacum  
(Tobacco) 
None Lab colony 
 
None Enterococcus Culture-
independent 
Brinkmann, 2008 
       
Artificial diets       
NCSU Insectary None Lab colony Bleach Pediococcus 
Micrococcus, 
Staphylococcus   
Culture-
dependent 
van der Hoeven, 
2008 
 Kanamycin, 
Streptomycin 
Lab colony Bleach Paenibacillus, 
Microbacterium, 
Bacillus, 
Methylobacterium 
Culture-
dependent 
 
       
USDA, Hamden 
formula
a 
None Carolina Biological Supply  Tween 80, 
Bleach 
Enterobacter, 
Klebsiella 
Culture-
independent 
Broderick, 2004 
       
 Penicillin, 
Gentamicin, 
Rifampicin, 
Streptomycin 
Carolina Biological Supply  Tween 80, 
Bleach 
None Culture-
independent 
 
a  Contains Chlortetracycline 
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raised on nightshade, Bacillus spp., Serratia spp. and yeast (Candida) were the dominant 
microbes isolated (27).  In M. sexta larvae raised on the natural diet of tobacco leaves 
Enterococcus spp. were the dominant species isolated from the intestine (15). In contrast, 
a range of Gram-positive and Gram-negative bacteria were isolated from the intestines of 
larvae derived from bleached eggs raised on different artificial diets (16, 28).  Addition of 
antibiotics to the diet dramatically altered or eliminated the microbial gut community.  
I characterized the microbial community of M. sexta larvae grown on two 
different commercially available artificial diets, North Carolina State University (NCSU) 
diet and Gypsy moth diet. In each experiment a portion of the population was used to 
dissect the intestine to analyze the gut microbial community and a portion was exposed to 
S. carpocapsae to assess the microbial population in the hemolymph of infected larvae 
during the early phase of infection (Table 3). Following dilution plating, colonies were 
grouped based on morphology and pigmentation. Representative isolates were subjected 
to 16S rRNA gene sequencing for species identification. All species could be 
distinguished by colony morphology and pigmentation with the exception of E. faecalis 
and Aerococcus viridans that were combined in a single group.  
In insects raised on NCSU diet, Klebsiella oxytoca and Staphylococcus 
saprophyticus were the dominant gut microbes in Exp. 1, while E. faecalis and S. 
saprophyticus were dominant in Exp. 2. In insects raised on Gypsy moth diet 
Enterococcus mundtii, S. saprophyticus and yeast were major gut microbes in Exp. 3 
while yeast was the major gut microbe isolated in Exp. 4.  Thus, Enterococcus spp. and S. 
saprophyticus were dominant in insects raised on both diets while yeast was more 
prevalent in insects raised on the Gypsy moth diet.   
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                TABLE 3. Transfer of microbiota from the gut to the hemolymph during natural infection of Manduca sexta  
 
Experiment Insect diet
 
Gut                           Hemolymph
 
  Major isolates  Major isolates CFU/ml
a 
1 NCSU Insectary K. oxytoca 
S. saprophyticus 
 
 K. oxytoca  
S. saprophyticus  
 
3.7 × 10
5 
1.0 × 10
4
  
 
2 NCSU Insectary E. faecalis 
 
S. saprophyticus 
 
 E. faecalis/A.viridans 
Yeast 
S. saprophyticus  
 
4.2 × 10
4 
2.2 × 10
4 
5.0 × 10
2 
 
3 Gypsy moth  E. mundtii 
Yeast 
S. saprophyticus 
 
 E. mundtii 
Yeast 
S. saprophyticus 
 
2.5 × 10
7 
4.3 × 10
6 
1.0 × 10
4 
 
4 Gypsy moth Yeast 
 
 Yeast 
 
1.6 × 10
4 
 
                       a 
All CFU/ ml values measured at 7.5 h post-infection except Experiment 3 for which it was at 18  
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To determine if gut microbiota can translocate from the gut to the hemocoel during 
natural infection, hemolymph was dilutionally plated and the resulting colonies were 
characterized as described above. In all experiments the major isolates identified in the 
gut were also microbes that were dominant in the hemolymph early in infection (Table 
3). In control experiments no colonies were obtained from hemolymph collected from 
uninfected insects. These findings indicate that gut microbes are translocated into the 
hemocoel when the invading nematode penetrates the intestine of M. sexta. 
 
2.2.2. Microbial population dynamics in hemolymph of M. sexta infected with S. 
carpocapsae IJs 
To assess temporal fluctuations in microbial populations in the hemocoel in M. 
sexta naturally infected with S. carpocapsae in Exp. 2 hemolymph was obtained at 
various times post-infection and microbial species were identified as described above. 
The microbial population was diverse early in infection at 5 h and 7.5 h (FIG. 2.1).  E. 
faecalis/A. viridans were dominant while S. saprophyticus, other minor species and yeast 
were present at lower levels. X. nematophila was detectable at 7.5 h. By 18 h X. 
nematophila became the dominant species, E. faecalis/A. viridans persisted and the other 
species disappeared. The relative levels of E. faecalis/A. viridans increased at 24 h while 
X. nematophila was dominant at later times.  The growth of X. nematophila and E. 
faecalis/A. viridans in the hemolymph at each time point was monitored in the same 
experiment (Exp. 2) by determining colony forming units per ml (CFU/ml) of 
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FIG. 2.1. Microbial population dynamics in hemolymph of M. sexta naturally 
infected with S. carpocapsae. M. sexta larvae were exposed to S. carpocapsae for 
various times over a 48 h period. At indicated times hemolymph was extracted and 
serially diluted and resulting colonies were grouped by morphology and pigmentation. 
Species were identified by 16S rRNA gene sequencing. The species isolated were: X. 
nematophila (black bars), E. faecalis/A. viridans (light gray striped bars), yeast (dark gray 
bars), S. saprophyticus (white hatched bars), and other minor bacteria (white bars), 
including small percentages of Pseudomonas spp. and Brachybacterium spp. Data are 
represented as the percentage of each species relative to the total colonies counted at each 
timepoint.  
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FIG. 2.2. Microbial population dynamics in hemolymph of M. sexta naturally 
infected with S. carpocapsae. Total colony forming units per ml of hemolymph 
(CFU/ml) of X. nematophila (black bars) and E. faecalis/A. viridans (light gray striped 
bars) obtained at each time point shown in FIG. 2.1.   
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FIG. 2.3. Microbial population dynamics in hemolymph of M. sexta naturally 
infected with S. carpocapsae. 16S rRNA gene clones obtained from total microbial 
genomic DNA in infected insect hemolymph (see FIG 2.1) were sequenced and species 
were identified by BLASTN analysis. Species identified were X. nematophila (black 
bars), E. faecalis (light gray bars), A. viridans (white striped bars), S. saprophyticus 
(white hatched bars), and other bacteria (white bars).  “Others” represent minor 
percentages of: Brachybacterium spp., Klebsiella spp., Paracoccus spp., and Pediococcus 
spp. Data are represented as percentage of clones of each species relative to the total 
clones at each time point. 
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 hemolymph (FIG. 2.2).  At 7.5 h the population of E. faecalis/A. viridans had reached 
4x10
4 
CFU/ml while X. nematophila was present at 10
3 
CFU/ml. By 18 h X. nematophila 
had reached 4x10
5 
CFU/ml while the population of E. faecalis/A. viridans increased at a 
slower rate during this period but began to increase more rapidly by 24 h. At later times 
the population of X. nematophila increased rapidly while E. faecalis/A. viridans 
continued to increase at a slower rate than X. nematophila resulting in the higher 
percentage of X. nematophila seen in FIG. 2.1. In these experiments it was difficult to 
reliably obtain CFU/ml data after 48 h due to degradation of insect tissues and increased 
viscosity of the hemolymph.  
To determine if the culture-dependent analysis of microbial population dynamics 
was representative and not biased against unculturable species I carried out culture-
independent analysis of the microbial community in the hemolymph of infected insects in 
the same experiment (Exp. 2, FIG. 2.3). This approach also allowed us to determine the 
relative levels of E. faecalis and A. viridans in the population. The culture-independent 
analysis identified the same pattern of population fluctuation as was observed with the 
culture-dependent approach. The microbial population was diverse early in infection (7.5 
h).  At this time E. faecalis was dominant while other species were present at lower 
levels. By 18 h and 24 h X. nematophila had become the dominant species, E. faecalis 
persisted and the other species including A. viridans and S. saprophyticus had 
disappeared. X. nematophila was the only species isolated at later times in the culture-
independent analysis most likely due to the limited number of 16S rRNA gene clones 
sequenced in this experiment.  
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The natural infection experiment was repeated and temporal fluctuations in 
microbial populations in the hemocoel were monitored as described above. The results 
were similar to Exp. 2 except that S. saprophyticus was not detected during the early 
phase of infection and the level of yeast was noticeably higher. By 18 h X. nematophila 
was dominant, E. faecalis/A.viridans continued to persist and yeast had disappeared. 
Together, these findings establish that diverse gut microorganisms translocate into the 
hemocoel during invasion, with E. faecalis/A. viridans dominating early in infection. By 
18 h X. nematophila becomes the dominant species, E. faecalis/A. viridans persist (FIG. 
2.2) while other species disappear. 
 
2.2.3. Sensitivity of competitors to X. nematophila antibiotics  
To assess the possibility that antibiotics produced by X. nematophila contributed 
to the population fluctuations observed during infection, the sensitivities of S. 
saprophyticus, E. faecalis, A. viridans and yeast were analyzed by diffusion overlay 
assays (FIG. 2.4). S. saprophyticus was the most sensitive (27 mm zone of inhibition) to 
antibiotics produced by X. nematophila, A. viridans was moderately sensitive (16 mm) 
and yeast was somewhat less sensitive (12 mm). Interestingly, E. faecalis was the most 
resistant strain (9 mm, hazy zone) suggesting that its persistence during later stages of 
infection may be due, in part, to its resistance to X. nematophila antibiotics.   
 
2.2.4. In vivo competition in M. sexta  
During natural infection competitors such as S. saprophyticus, A. viridans and 
yeast disappeared early in infection while E. faecalis persisted (FIG. 2.1, 2.2, 2.3). To 
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FIG. 2.4. Antibiotic activity of X. nematophila against the microbes present in the 
insect hemolymph. Antibiotic overlay assays were performed with X. nematophila 
against the following strains obtained from infected insect hemolymph: S. saprophyticus, 
A. viridans, yeast, E. faecalis. The diameter of the zone of inhibition is proportional to the 
sensitivity of the competitors to X. nematophila antibiotics.  
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FIG. 2.5. In vivo growth of isolates in M. sexta hemocoel after injection. Insects were 
injected with 10
4 
CFU/insect of X. nematophila (black bars), E. faecalis (light gray bars), 
S. saprophyticus (white hatched bars) or A. viridans (white striped bars). Hemolymph 
recovered at 8 and 24 h post-injection was dilutionally plated. Data are represented as 
CFU/ml of each bacterial species at 8 and 24 h. Statistically significant differences 
(P<0.05) between the two timepoints in a group are indicated by an asterisk. Statistical 
analysis was performed using a two-tailed paired Student’s t-test. 
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further dissect the competitive events that occur early in infection we assessed the ability 
of individual species to compete with X. nematophila. To first determine if the individual 
species were able to persist and proliferate alone in the hemocoel, S. saprophyticus, 
E.faecalis and A.viridans were injected individually into M. sexta and growth was 
monitored for 24 h. S.saprophyticus persisted at 8 h and the cell density increased at 24 h 
(FIG. 2.5). E. faecalis persisted at 8 h while cell density decreased at 24 h. A. viridans 
was present at low levels at 8 h and was detectable at lower levels at 24 h. Thus, all 
strains persisted at 24 h, with S. saprophyticus able to survive better than either E. 
faecalis or A. viridans. 
To evaluate the competitive interactions between S. saprophyticus and X. 
nematophila, both bacteria were co-injected into M. sexta (FIG. 2.6. A). S. saprophyticus 
was eliminated by 24 h when co-injected with X. nematophila. In contrast, S. 
saprophyticus was not eliminated by 24 h when co-injected with E. faecalis (FIG. 2.7). S. 
saprophyticus and E. faecalis also did not display any antibiotic activity against each 
other in overlay assays (FIG. 2.8). When E. faecalis was co-injected into M. sexta (FIG. 
2.6. B) it proliferated to high levels in the presence of X. nematophila while it did not 
grow significantly better when co-injected with S. saprophyticus (FIG. 2.7). These 
findings are consistent with the population dynamics we observed during natural 
infection and suggest that relative antibiotic resistance and possible syntrophic effects 
when present along with X. nematophila allowed E. faecalis to grow in the insect 
hemocoel. Another possibility could be the suppression of the host immune system by X. 
nematophila which might aid E. faecalis growth (see below). 
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FIG. 2.6. In vivo growth after 1:1 co-injections of X. nematophila with S. 
saprophyticus or E. faecalis into M. sexta. A. Insects were co-injected with a 1:1 
mixture of X. nematophila (black bars) and S. saprophyticus (white hatched bars). 10
4 
CFU/insect of each species were injected. B.  Insects were co-injected with a 1:1 mixture 
of X. nematophila (black bars) and E. faecalis (light gray bars). 10
4 
CFU/insect of each 
species were injected. Hemolymph recovered at 8 and 24 h post-injection was 
dilutionally plated. Data are represented as CFU/ml of each bacterial species at 8 and 24 
h.
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FIG. 2.7. In vivo growth after 1:1 co-injection of E. faecalis and S. saprophyticus into 
M. sexta. Insects were co-injected with a 1:1 mixture of E. faecalis (light gray bars) and 
S. saprophyticus (white hatched bars). 10
4 
CFU/insect of each species were injected. 
Hemolymph recovered at 8 and 24 h post-injection was dilutionally plated. Data are 
represented as CFU/ml of each bacterial species at 8 and 24 h.  
49         
 
 
FIG. 2.8. Antibiotic overlay assay testing mutual activity of E. faecalis and S. 
saprophyticus. The lack of a zone of inhibition indicates that E. faecalis and S. 
saprophyticus do not possess antibiotic activity against each other.  
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FIG. 2.9. In vivo competition between X. nematophila and E. faecalis in M. sexta co-injected at varying ratios. A.  Insects were 
injected individually with 10
5 
CFU/insect of either X. nematophila (black bars) or E. faecalis (light gray bars). B.  Insects were co-
injected with a 1:10 mixture of X. nematophila (10
4 
CFU/insect) and E. faecalis, (10
5 
CFU/insect). C. Insects were co-injected with a 
10:1 mixture of X. nematophila (10
5 
CFU/insect) and E. faecalis (10
4 
CFU/insect).   Hemolymph recovered at 8 and 24 h post-
injection was dilutionally plated. Data are represented as CFU/ml of each bacterial species at 8 and 24 h.  
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During the early phase of natural infection the levels of E. faecalis were significantly 
higher than those of X. nematophila (FIG. 2.1, 2.2, 2.3). To more closely mimic the 
relative cell density that occurs during natural infection, M. sexta was co-injected with a 
10:1 ratio of E. faecalis/X. nematophila (FIG. 2.9. B). As expected, E.faecalis 
proliferated in the presence of X. nematophila.  Since the cell density of X. nematophila 
was significantly higher than E. faecalis at later times in infection, I also  co-injected M. 
sexta with 10-fold more X. nematophila than E. faecalis (FIG. 2.9. C). Again, E. faecalis 
was able to proliferate in the presence of X. nematophila. These findings show that the 
growth of E. faecalis in the hemolymph was enhanced by the presence of X. nematophila 
(compare FIG. 2.5 with FIG. 2.6 and 2.9) even when the latter was present at 10-fold 
higher levels.   
 
2.2.5. Induction of antimicrobial peptide transcripts by E. faecalis is suppressed by 
X. nematophila 
 Proliferation of E. faecalis in the presence of X. nematophila suggested that this 
strain might benefit from suppression of the host immune response by X. nematophila. To 
explore this possibility, qRT-PCR analysis was performed to determine relative transcript 
levels of cecropin in insects injected with either X. nematophila or E. faecalis, or co-
injected with both bacteria. Cecropin transcript was detectable in insects injected with X. 
nematophila and was induced to high levels in insects injected with E. faecalis relative to 
PBS-injected controls (FIG. 2.10). In insects co-injected with both bacteria the transcript 
level of cecropin was similar to or less than those injected with X. nematophila alone. 
These results support the idea that X. nematophila suppresses AMP gene expression  
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FIG. 2.10. Relative cecropin transcript levels in insects injected with E. faecalis and 
S. saprophyticus alone, and co-injected with E. faecalis and X. nematophila. Fifth 
instar M. sexta larvae were injected with X. nematophila (black bars), E. faecalis (gray 
bars), S. saprophyticus (white hatched), or co-injected with both X. nematophila and E. 
faecalis (white horizontal striped bars). Insects injected with PBS (white bars) served as a 
negative control for immune activation. RNA extracted at 16 h post-injection from fat 
body tissue was converted to cDNA and the cDNA was used to assess the relative 
transcript levels of the antimicrobial peptide cecropin (highly induced upon bacterial 
challenge). Statistically significant differences between two groups are indicated by 
different letters between the groups. 
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induced by the presence of E. faecalis. I also found that the ability of S. saprophyticus to 
survive in the hemolymph when injected alone (FIG. 2.5) could be attributed, in part, to 
the lack of induction of cecropin transcripts relative to the control (FIG. 2.10). 
 
2.2.6. E. faecalis isolated from the gut is pathogenic towards M. sexta 
The persistence of E. faecalis during the early phase of infection and virulence of 
a clinical strain of E. faecalis towards M. sexta (18) raised the possibility that E. faecalis 
isolated from the insect gut would be pathogenic towards M. sexta. To explore this 
possibility, virulence of the gut strain was compared to the clinical strain of E. faecalis 
and X. nematophila (FIG. 2.11). At 22 h, 50% of the insects had died (LT50, 22 h) when 
injected with X. nematophila at a dose of 10
4 
CFU/insect while all of the insects were 
dead by 25 h (LT100, 25 h). The gut strain of E. faecalis was also virulent at a higher dose 
of 10
6
 CFU/insect (LT50, 27 h; LT100, 43 h) while the clinical strain was less virulent 
(LT50, 43 h) and was not able to kill 100% of the injected insects. In contrast, S. 
saprophyticus injected at a dose of 10
6
 CFU/insect did not result in mortality of M. sexta 
larvae (data not shown). These results, combined with the evidence of persistence of E. 
faecalis during infection, suggest the possibility that E. faecalis may contribute to 
pathogenicity during natural infection of M. sexta.  
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FIG. 2.11. Comparison of the virulence of E. faecalis (gut isolate), E. faecalis 
(OG1RF), and X. nematophila towards M. sexta. Insects were injected with E. faecalis 
at a dose of either 10
6
  CFU/insect (squares), 10
5
  CFU/insect (upright triangles) or 10
4 
 
CFU/insect (inverted triangle). The E. faecalis (gut isolate) is represented with open 
symbols and E. faecalis OG1RF is represented by closed symbols.  Insects injected with 
X. nematophila (10
4 
CFU/insect) are represented by closed circles. Survival was 
monitored over a period of time and virulence is depicted as percent survival.  
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2.3. Discussion 
The role of gut microbiota in normal health, development and disease 
susceptibility has been extensively examined in several animals (28-30). The movement 
of bacteria into and across intestinal epithelial cells is a major source of diseases 
originating from the gastrointestinal tract. Whether native gut microbiota are translocated 
into the hemocoel during natural infections of M. sexta with entomopathogenic 
nematodes had not been previously studied. Here I characterize the gut microbiota of M. 
sexta and the translocation of microbes into the hemocoel during the early phase of 
infection by S. carpocapsae.   
I show that gut microbes were translocated into the hemocoel of M. sexta 
naturally infected with S. carpocapsae. During the early phase of infection the initial 
population was diverse and reached cell densities of ~10
5
 CFU/ml while X. nematophila 
was barely detectable at this time. The relatively high microbial load was unexpected 
since the innate immune response is rapidly induced in the presence of bacteria and yeast 
(11, 31).  Within hours after injection of bacteria, activated hemocytes engulf bacterial 
invaders and pattern recognition proteins are induced. Microaggregation of hemocytes 
has been observed 4 h after injection of M. sexta with E. faecalis (18) and Salmonella 
enterica (32), and AMP genes were induced 9 h after injection of Salmonella enterica 
(32). In Spodoptera exigua numerous immune response genes were induced 8 h after 
injection of either E. coli or Flavobacterium (14). Several factors could account for the 
microbial load observed during the early phase of infection. Since AMPs are secreted into 
the insect intestine (11) it is a possibility that native microbiota may develop tolerance to 
the host immune response. They might also be able to avoid host immune mediators. 
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Whatever the mechanism, the induction of the immune response is apparently not 
sufficient to prevent gut microbes from proliferating in the hemolymph. In addition, X. 
nematophila derived antimicrobial compounds would not be present at appreciable levels 
during early infection since this bacterium is present at low cell density at that time. 
Antibiotic activity was not detected until 36 h after G. mellonella was injected with S. 
carpocapsae (20).  Thus, during the early phase of infection competitors benefit from an 
apparently insufficient immune response and minimal antimicrobial deterrence. 
As shown previously, gut microbiota of M. sexta can vary and may be influenced 
by diet (TABLES 2 and 3). Enterococcus species were major isolates identified in Exp. 2 
and Exp. 3, consistent with previous observations in M. sexta raised on the natural diet of 
tobacco leaves (15). E. faecalis has been identified in the gut of Gypsy moth larvae raised 
on 5 different diets (16). It was proposed that E. faecalis could modify the high alkalinity 
of the larval gut and influence the microbial gut community. E. faecalis was also the 
dominant microbial species isolated from the gut of G. mellonella (33) and was the only 
bacterial species isolated from macerated G. mellonella (34). I show that during natural 
infection E. faecalis was present in the hemolymph by 5 h, persisted at 10 h and 
subsequently increased as the cell density of X. nematophila increased. A similar pattern 
was observed in M. sexta co-injected with E. faecalis and X. nematophila. I also found 
that E. faecalis was relatively resistant to antibiotics produced by X. nematophila. 
Additionally, the transcript level of the AMP cecropin was suppressed by X. nematophila 
when it was co-injected with E. faecalis, which by itself induced the up-regulation of this 
gene (FIG. 2.10). These findings suggest that the combined effect of immune suppression 
by X. nematophila, the relative antibiotic resistance of E. faecalis and possible syntrophic 
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interactions may create conditions for E. faecalis to proliferate. Furthermore, the native 
E. faecalis had, by 18 h, reached a cell density that was shown to be lethal to M. sexta 
(FIG. 2.11).  Thus, in insects in which E. faecalis is present in the gut, invasion by 
entomopathogenic nematodes could result in its translocation to the hemocoel where it 
may contribute to virulence. However, E. faecalis was not essential for virulence since 
mortality of M. sexta lacking E. faecalis was similar to when it was present (data not 
shown).  
During later phases of infection (e.g. 18 h) X. nematophila was dominant and E. 
faecalis cell density had increased while strains such as S. saprophyticus, A. viridans and 
yeast had disappeared. These findings correlated with sensitivity to the antibiotics of X. 
nematophila. In a previous study in which Gram-negative bacteria were sampled in the 
hemolymph of G. mellonella naturally infected with S. carpocapsae, Pasteurella sp. was 
the predominant species isolated at 6 h and 12 h while it had disappeared by 18 h when X. 
nematophila was the only species isolated (35).  The reciprocal relationship between 
increasing cell density of X. nematophila and reduction of competitors suggest that 
production of antimicrobial compounds may play a role in the population fluctuations in 
the infected host.  X. nematophila produces more than 20 antimicrobial compounds when 
grown in pure culture in complex media. However, little is known about antibiotic 
production in natural host environments. Proline, which is present at high levels in the 
hemolymph of G. mellonella, was shown to stimulate production of some secondary 
metabolites by X. nematophila grown in tryptone-yeast extract broth (36). The growth of 
X. nematophila in mixed cultures in the hemolymph also creates the potential of cross-
species signaling that may induce production of antibiotics not detected in pure cultures 
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(37). Further studies in M. sexta naturally infected with S. carpocapsae and antibiotic-
deficient strains of X. nematophila will provide greater insight into the role of 
antimicrobial compounds in natural host environments.  
The present findings suggest that S. carpocapsae development and colonization is 
unlikely to occur in a monoculture of X. nematophila. The proliferation of competitors 
could play a role in both determining the host range of S. carpocapsae and susceptibility 
of the host to infection. Also, since the gut microbiota can vary considerably, the types of 
competitors that are encountered in the hemolymph of different hosts may differentially 
affect the ability of S. carpocapsae to reproduce.  For example, co-inoculation of some 
species of Xenorhabdus with axenic S. carpocapsae did not alter nematode reproduction 
while other species prevented reproduction (38). Similarly, different gut microbiota may 
have either neutral or antagonistic effects on nematode reproduction.  How variability of 
the insect gut microbiota influences S. carpocapsae development and colonization, and 
insect mortality remains to be determined. It is becoming increasingly apparent that 
interspecies competition that occurs during natural infection by entomopathogenic 
nematodes is complex, influenced by the microbial community of the insect gut, insect 
immune response, temporal and environmental control of antimicrobial products and 
other microbe-nematode interactions yet to be identified.  
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Chapter Three 
 
Differential Role of Antibiotics in the Life Cycle of 
Xenorhabdus nematophila 
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3.0. Introduction 
Competition among microorganisms often occurs in multispecies populations, 
commonly for space and nutrients, where bacteria employ various strategies to affect the 
outcome in their favor. Normally, competition for limiting factors can be divided into two 
general categories: exploitative competition, and interference competition (1). In 
exploitative competition, the limiting nutrients are quickly utilized without direct 
interaction between competitors. Interference competition, on the other hand, makes use 
of direct, antagonistic interactions. One of the effectors of interference competition by 
bacteria is antimicrobial compounds.   Xenorhabdus nematophila, a symbiotic, 
entomopathogenic bacterium, is a known producer of a plethora of antimicrobial 
compounds that are believed to assist in competition. Several of its secondary metabolite 
antimicrobial compounds have been characterized and several have as yet unknown 
activities, while there is genetic potential for the production of still more that are 
undiscovered. Whether these antimicrobial compounds play a role in interspecies 
competition, which could directly or indirectly affect symbiotic interactions with the 
nematode partner or virulence towards an insect host, is still unknown. Our tripartite 
model system involving the pathogenic bacterium Xenorhabdus nematophila, an 
entomopathogenic nematode and an insect host provides a tractable model to identify 
biologically relevant competitors, and study the role of X. nematophila antibiotics in 
competition.    
Xenorhabdus nematophila exhibits two distinct roles in its life cycle (2-5). In its 
first role as a symbiotic partner it maintains a species-specific mutualistic relationship 
with the entomopathogenic nematode Steinernema carpocapsae. X. nematophila resides 
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in a specialized region of the anterior midgut of the infective juvenile (IJ) stage of the 
nematode (6). The IJs invade soil-dwelling insect larvae through natural openings such as 
the mouth or anus, and enter the body cavity (hemocoel) of the insect. Herein lies the 
second role of X. nematophila, an insect pathogen.  Once in the hemocoel, the bacteria 
are released and Xenorhabdus brings about the death and bioconversion of the insect 
larva by suppressing the insect immune response and producing toxins, cytotoxins and 
hemolysins (4).    
The most well studied antimicrobial compounds produced by bacteria are small 
molecule antibiotics. Antibiotics are secondary metabolites and are often produced by 
multi-enzyme assemblies called non-ribosomal peptide synthetases (NRPS) and/or 
polyketide synthetases (PKS). Both of these enzyme assemblies are multi-modular and 
function using various domains (FIG. A.3). The major antimicrobial compound produced 
by X. nematophila in nutrient-rich broth cultures is the antibiotic xenocoumacin (Xcn), a 
water-soluble, benzopyran-1-one compound, which is a product of a 14 gene NRPS-PKS 
hybrid cluster (7, 8). Xenocoumacin exists in two forms: Xcn1, the more active form that 
possesses antibacterial (against both Gram-positive and -negative bacteria) and antifungal 
activities, and the less active form, Xcn2, which lacks antifungal activity (7). In the 14 
gene biosynthetic cluster, there are 2 NRPS genes (xcnA, xcnK) and 3 PKS genes (xcnF, 
xcnH, xcnL). The genes xcnM and xcnN are responsible for conversion of Xcn1 into Xcn2 
(8-10). Xcn has been shown to be produced in the wax worm, Galleria mellonella, where 
water extracts from macerated larvae infected with X. nematophila were shown to contain 
both Xcn1 and Xcn2 (11). But the significance of xenocoumacin in the life cycle, 
especially in the respective host organisms, has never been demonstrated.  
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Several other NRPS gene clusters have been identified in the X. nematophila 
genome. We had arbitrarily assigned these clusters letter designations A-F (FIG. 3.1). 
The products of two of these clusters (B and D) have since been characterized. Cluster B 
consists of 3 NRPS genes that produce lysine-rich cyclolipopeptides called PAX peptides 
(peptide antibiotics-Xenorhabdus) that possess antifungal activity against human and 
plant fungal pathogens, and low activity against Gram-positive and -negative bacteria 
(12, 13). Cluster D consists of 3 NRPS genes that produce 6 linear, non-polar peptides 
(rhabdopeptides) that possess antiparasitic activity against protozoan parasites and 
cytotoxic activity against insect hemocytes (14).  Rhabdopeptides were shown to be 
produced in the infected insect G. mellonella, in later stages of infection. In addition, the 
cyclic depsipeptide xenematide, which has activity against some Gram-positive and 
Gram-negative bacteria, was shown to be synthesized by a large stand-alone NRPS gene. 
(TABLE 1) (15, 16). Four other NRPS and NRPS-PKS gene clusters with the potential to 
produce antimicrobial compounds have been identified in the genome of X. nematophila 
(TABLE 4). These include cluster A (XNC1_2038, 2039, 2040), cluster E  (XCN1_2299, 
2300) and cluster F (XNC1_2464, 2465, 2466, 2467) and the hybrid NRPS-PKS cluster 
C containing two NRPS genes (XNC1_1762, 1763) and three PKS genes (XNC1_1756, 
1757, 1764). These NRPS clusters and genes have not been studied so far for their 
biosynthetic capacity. In addition, the large stand-alone NRPS gene, XCN1_2022 (xtpS), 
is known to encode xenotetrapeptide but its function remains unknown (17).   
Other X. nematophila compounds with known antimicrobial activity but that do 
not yet have a gene cluster associated with them are indole-derivatives (active against 
both Gram-positive and -negative bacteria) and benzylideneacetone (antibacterial against  
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FIG. 3.1. NRPS gene clusters in the genome of X. nematophila. NRPS genes are 
colored red and blue and the PKS genes are colored yellow. The genes in red were 
inactivated for mutant construction. 
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  TABLE 4. NRPS and PKS clusters in X. nematophila with unidentified activity 
    
Cluster Type Number of genes Genes 
A NRPS 3 XNC1_2040, 2039, 2038 
 
C NRPS 2 XNC1_1763, 1762 
 PKS 3 XNC1_1764, 1757, 1756 
 
E NRPS 2 XNC1_2299, 2300 
 
F NRPS 4 XNC1_2764, 2765, 2766, 2767 
 
 - NRPS 1 XNC1_2022 
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five plant pathogenic strains tested) (18-20). Nematophin, another indole-derived 
compound, has antibacterial activity against Bacillus sp., Staphylococcus spp. and some 
antifungal activity,and is not known to be synthesized by NRPS or PKS genes (21). Other 
small molecules include the non-polar di-peptide derivatives xenortide A and B that lack 
antibacterial, antifungal, and insecticidal activity against the strains tested (15).  
While the activities of some of these compounds have been elucidated, it largely 
remains unclear what their role is in natural biological conditions. Antibiotic production 
is mostly studied in laboratory culture conditions, often in nutrient-rich media, when 
antibiotics are produced in high concentrations. Additionally, these compounds are tested 
against a chosen set of indicator organisms, which may not have any biological relevance 
to the producer organism. It has been proposed that antibiotics are usually produced in 
sub-inhibitory concentrations in natural environments and under such conditions can 
participate in signaling (22-26). Therefore, these compounds purported to have 
antimicrobial activity, might not be present in high enough concentrations in the natural 
environment, and might demonstrate altogether different functions.  A link that connects 
all the NRPS, PKS clusters together is the enzyme phosphopantetheinyl (Ppant) 
transferase. This enzyme, the product of the ngrA gene, attaches the PPant moiety to the 
transfer (PCP) domain of NRPS and PKS enzymes (FIG. A.4). A mutant in this gene 
created in the related bacterium Photorhabdus luminescens was shown to lack antibiotic 
activity and was unable to support nematode growth (27). This finding suggests that the 
products of these gene clusters can have other functions, such as a developmental signal 
for the nematode partner. 
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We have previously demonstrated that the gut microbiota of the insect host 
Manduca sexta translocates to the hemocoel during natural infection with the nematode 
Steinernema carpocapsae harboring X. nematophila, and are potential competitors (28). 
During early infection some competitors were eliminated such as Staphylococcus 
saprophyticus that was sensitive to X. nematophila antimicrobials. Another gut microbe, 
Enterococcus faecalis that was relatively resistant to antimicrobials, was dominant during 
early stage infection and proliferated in the hemolymph along with X. nematophila.  In 
the present study we address several unanswered questions. What is the role of 
xenocoumacin in competition against the biologically relevant competitors E. faecalis 
and S. saprophyticus? Do any of the as yet uncharacterized NRPS, PKS clusters produce 
antimicrobial compounds? Does the outcome of the competition change depending on 
growth conditions? To address these questions we created NRPS mutant strains and a 
ngrA mutant defective in synthesis of all NRPS, PKS-derived antimicrobials. 
Additionally, we addressed the question of whether these compounds have one or more 
functions in the natural host environment, which might affect the symbiotic or pathogenic 
relationships of X. nematophila.  
 
 
3.1. Materials and Methods 
3.1.1. Bacterial strains and growth conditions  
All strains and plasmids used in this study are listed in TABLE 5. Cells were 
routinely grown at 30°C in either Luria-Bertani broth (LB) or on LB agar plates (15 g/l
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                             TABLE 5. Bacterial strains and plasmids used in this study 
 
Strain or plasmid Relevant genotype, phenotype or characteristic(s) 
Source or 
Reference 
Strains 
  X. nematophila 
  AN6/1 Wild-type, phase 1 variant; Amp
r
 Laboratory stock 
ΔxcnKL AN6/1 ΔxcnKL::Kmr D. Park 
F AN6/1 2467::Cm
r
 This study 
ngrA AN6/1 1028::Cm
r
 This study 
ΔxcnKL:A AN6/1 ΔxcnKL::Kmr 2040::Cmr This study 
ΔxcnKL:B AN6/1 ΔxcnKL::Kmr 2783::Cmr This study 
ΔxcnKL:C AN6/1 ΔxcnKL::Kmr 1763::Cmr This study 
ΔxcnKL:D AN6/1 ΔxcnKL::Kmr 2228::Cmr This study 
ΔxcnKL:E AN6/1 ΔxcnKL::Kmr 2300::Cmr This study 
ΔxcnKL:F AN6/1 ΔxcnKL::Kmr 2467::Cmr This study 
E. coli S17-λpir 
recA, thi, pro, hsd(R-M+). RP4-2Tc::Mu Km::Tn7 in the 
chromosome Laboratory stock 
E. faecalis Manduca sexta gut isolate 
 S. saprophyticus Manduca sexta gut isolate 
 Plasmids 
  pSTBlue-1 Cloning vector: Amp
r
 Km
r
 Novagen 
pKnock-Cm
r
 Broad-host-range suicide vector; Cm
r
 RP4 oriT oriR6K D. Saffarini 
pKnock-A Internal fragment of 2040 cloned into pKnock-Cm
r
 This study 
pKnock-B Internal fragment of 2783 cloned into pKnock-Cm
r
 This study 
pKnock-C Internal fragment of 1763 cloned into pKnock-Cm
r
 This study 
pKnock-D Internal fragment of 2228 cloned into pKnock-Cm
r
 This study 
pKnock-E Internal fragment of 2300 cloned into pKnock-Cm
r
 This study 
pKnock-F Internal fragment of 2467 cloned into pKnock-Cm
r
 This study 
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agar) (29). After preparation, media were maintained in the dark. Strains grown overnight 
in LB broth (supplemented with ampicillin, chloramphenicol and kanamycin to a final 
concentration of 50, 25 and 30 mg/ml respectively, when required) were subcultured 
(1:20) in 5 ml of fresh LB broth and growth was monitored by turbidity via optical 
density measurement at 600 nm (OD600). Final bacterial cultures were normalized using 
OD600 values. Grace’s insect culture medium (Gibco) was used to dilute cultures for 
insect injections and dilutional plating. 
 
3.1.2. Construction of the NRPS and ngrA mutant strains  
The approach of insertional inactivation of the appropriate genes was utilized to 
create the mutant strains. Briefly, for each gene primers were designed to amplify a 200–
800 bp internal fragment located near the 5′ end of the gene. The amplified products were 
purified with GeneClean Turbo kit (MP Biomedicals), followed by end conversion and 
subsequent blunt end-ligation into the EcoRV site of pSTBlue-1 vector (Novagen). 
Several of the resulting recombinant colonies were selected and analyzed by colony PCR 
using a T7 and SP6 primer pair from the regions flanking the EcoRV site of pSTBlue-1 to 
confirm the size of the cloned fragment. A colony having the desired plasmid was grown 
overnight and the plasmids containing the inserts were purified using the QIAprep Spin 
Miniprep kit (Qiagen). A PstI–XbaI fragment containing either 2040, 2783, 1763, 2228, 
2300, 2467, or 1028 (ngrA) internal gene fragment was gel-purified and ligated into the 
conjugal suicide vector pKnock-Cm (30). The resultant recombinant plasmids were 
transformed into electrocompetent E. coli S17-λpir and conjugally transferred into the 
wild-type strain of X. nematophila. The 2040, 2783, 1763, 2228, 2300, 2467 plasmids 
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were also conjugally transferred to the ΔxcnKL strain of X. nematophila to generate 
double mutants in the xenocoumacin deletion background strain. Selection on ampicillin 
and chloramphenicol identified the mutants in which the recombinant pKnock-Cm had 
integrated into the chromosome within the respective gene by single-cross-over 
homologous recombination, leading to gene disruption, which was confirmed by PCR. 
The primers used in this study are mentioned in TABLE 6. 
 
3.1.3. Antibiotic overlay assay  
Six microliter volume of exponential phase subcultures of X. nematophila were 
spotted on LB agar plates and incubated. After 24 h of growth, the bacteria were exposed 
to chloroform fumes for 30 min followed by air drying for 30 min.  Five hundred 
microliters of overnight culture of the indicator bacterial strain was added to 6 ml top 
agar (LB with 0.7% agar) which was then poured to form an overlay on the X. 
nematophila colonies (2, 31). The plates were incubated at 30°C for 48 h. Zones of 
inhibition were measured in millimeters. The overlay assays were performed twice, with 
nearly identical results. 
 
3.1.4. In vitro competitions in LB and Grace’s 
The appropriate X. nematophila strains, E. faecalis and S. saprophyticus 
subcultures were set up in either LB or Grace’s medium, depending on the condition 
chosen. Cultures were allowed to grow till exponential phase and were normalized based 
on O.D.600. The competitions were set up by inoculating (1:20) fresh 5 ml LB or Grace’s 
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                   TABLE 6. Primers used in this study 
Gene, cluster or vector Primer Sequence (5'-3') Use 
ngrA XN_1028 F CATGTCATGCTGGCCTATTTTG Mutant construction 
XN_1028 R CAAATAGTGTCAGGCCAGATTGG Mutant construction 
XNC1_1028 OF ACCTCTACTCAAGTCACTAC Mutant screening 
Cluster A XNC1_2040 F TCTCTCAGTACGACTCAGCAAG Mutant construction 
XNC1_2040 R CTATCTTGTCTGTAGCGTTGTGAG  Mutant construction 
XNC1_2040 OF TCATGCAATCGTATCAACAACG  Mutant screening 
Cluster B XNC1_2783 F GCCAAACGATTAGAAGAAGCTCTC  Mutant construction 
XNC1_2783 R ACAGTGAATTGTGCAGGATCTTG Mutant construction 
XNC1_2783 OF TCAAATTGACCCTGACAAACG  Mutant screening 
Cluster C XNC1_1763 F CACTTACGGATATGCAGCAGG  Mutant construction 
XNC1_1763 R GTGTTGTTGCTGCCAATTGAC  Mutant construction 
XNC1_1763 OF TTTGGGAAAACTATTCTGATGTTG Mutant screening 
Cluster D XNC1_2228 F ACAGCATACCGCCAGAATTG  Mutant construction 
XNC1_2228 R TGAACCTTTAGCACTGGCAAT  Mutant construction 
XNC1_2228 OF TCAATGAGGCGTTAAATCAGGG Mutant screening 
Cluster E XNC1_2300 F CATCATGACAATATACCACCGGAAC  Mutant construction 
XNC1_2300 R AAGTTCATCCCAATGCTCTGTG  Mutant construction 
XNC1_2300 OF CTTTAAGCCAAGGAGTTACCCTG Mutant screening 
Cluster F XNC1_2467 F GACAGGCTCTCAATGGCAC Mutant construction 
XNC1_2467 R GGACTCTGTCACTTTGGTTGATAC  Mutant construction 
XNC1_2467 OF TGCCATAAAAGAGACGCTCCAG Mutant screening 
pKnock pKnock-F ACACAGGAACACTTAACGGCTGAC Mutant screening 
pKnock-R TGCGAAGTGATCTTCCGTCAGAG Mutant screening 
pSTBlue-1 SP6 ATTTAGGTGACACTATAG Mutant screening 
T7 promoter CTAATACGACTCACTATAGGG Mutant screening 
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with 1:1 mixtures of X. nematophila and competitor. The flasks were incubated at 30°C 
with shaking and dilution plating using the same medium at 0, 9, 18, 24 h was performed 
to obtain CFU/ml of the bacteria. The experiments were performed at least twice, 
yielding highly reproducible results. 
 
3.1.5. In vitro competitions in LB with pre-incubated X. nematophila 
Overnight cultures of the required X. nematophila strains were subcultured 1:20 in 
5 ml of Grace’s and incubated at 30°C for 10-11 h. Subcultures of the competitors E. 
faecalis and S. saprophyticus set up in 5 ml Grace’s were allowed to grow till exponential 
phase and were normalized based on O.D.600. These were added to the pre-inoculated 10-
11 h X. nematophila cultures to start the competition. Dilutions were made in Grace’s 
medium and plated on LB agar to determine the relative CFU/ml of the different strains 
at 0 and 24 h. The experiments were performed twice, with highly similar results. 
 
3.1.6. Antibiotic activity in cell-free supernatants from LB and Grace’s cultures 
Overnight cultures of wild-type X. nematophila were subcultured 1:20 in 5 ml of 
LB and Grace’s. The cultures were grown at 30°C, shaking, and at 6, 9, 12, 24 h post-
inoculation 1 ml of cultures were withdrawn from the flasks. This volume was 
centrifuged at 14,000 r.p.m for 1.5 min. The cell pellet thus obtained was discarded and 
the supernatant was sterilely filtered through 0.2 µm pore size filters (Millipore) attached 
to 3 c.c. syringe (B.D.). The sterile supernatants were frozen until used in the antibiotic 
assay. The O.D.600. measurement was taken and dilution plating in the respective medium 
was also performed at all the timepoints. For the antibiotic assay, 200 µl of a 1:50 
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dilution of the overnight culture of S. saprophyticus was used in a 96-well microtitre 
plate (BD) to which 20 µl of 1X and 0.5X diluted X. nematophila sterile supernatants 
were added. The microtitre plate was incubated at 30°C shaking, and 0 and 24 h O.D.600 
measurements were made to determine the levels of inhibition of S. saprophyticus.  
 
3.1.7. Sources, treatments and rearing of Manduca sexta larvae  
M. sexta eggs were obtained from the insect colony at the University of 
Wisconsin – Milwaukee. Eggs were placed in clean plastic cups along with diet and 
incubated in an insect incubator with at 16:8 h light:dark photoperiod at room 
temperature. After hatching, larvae were moved to clean boxes and provided fresh diet. 
Boxes were cleaned daily and larvae were fed regularly. The fourth instar stage was used 
for all experiments. Commercial premixed diet (North Carolina State University 
Insectary, hence referred to as NCSU) without added antibiotics was the diet used, 
prepared from individual ingredients. The diet was prepared according to supplier 
instructions (32).  
 
3.1.8. In vivo competitions  
X. nematophila (ΔxcnKL and ngrA), E. faecalis and S. saprophyticus were 
subcultured in LB broth, grown to exponential phase, normalized and diluted in Grace’s 
medium. For the competition experiments a 1:1 mixture of 10
4 
CFU/insect of the 
appropriate bacterial cultures was prepared in Grace’s medium.. Fifty microliters of the 
mixtures were injected per insect using BD 1ml Sub-Q, 0.45 mm x 16 mm syringes 
(Becton Dickinson Co.) mounted on a Stepper
™ 
Repetitive Dispensing Pipette (Dymax 
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Corp.). Fourth instar M. sexta larvae were anaesthetized by placing on crushed ice for 15-
20 min and the area around the horn was cleaned using 70% ethanol prior to injection. 
Grace’s medium was injected as a negative control. The insects were placed in plastic 
cups and hemolymph was collected at designated time points, followed by dilution 
plating on LB agar plates. Three to four larvae were used per time point and the 
experiment was performed three times, with reproducible results. The experiments were 
performed at similar times of the day, with similar feeding cycles for the insects. 
 
3.1.9. Nematode reproduction 
Twelve fourth instar M. sexta larvae per strain were used. The larvae were naturally 
infected by using S. carpocapsae IJs carrying either the wild-type AN6 or the ngrA
 
strain 
of X. nematophila. Briefly, IJs were washed using sterile water. Six larvae were placed on 
top of a moistened filter paper in a clean plastic cup. The appropriate volume of the IJ 
suspension resulting in 200 IJs/larvae was pipetted in random drops on the filter paper 
and the cup was placed in the insect incubator. Following insect death within 48 h, larvae 
were transferred to modified White water traps (33) containing 25 ml sterile distilled 
water (4 insects per trap). The emerging nematodes were counted in the trap until Day X 
after emergence and the average number of IJs per milliliter was determined. Four 
independent experiments were conducted, all yielding highly similar results. Data from a 
representative experiment is shown. 
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3.2. Results 
3.2.1. Analysis of NRPS gene clusters for antibiotic activity 
 We had shown previously that inactivation of the xcnA gene for xenocoumacin 
synthesis significantly reduced but did not eliminate antibiotic activity in an overlay 
assay using Micrococcus luteus as the indicator strain (8). The residual activity could be a 
product of additional NRPS gene clusters. The NRPS gene clusters for the PAX peptides 
and rhabdopeptides whose products were shown to possess antifungal and cytotoxic 
activity, respectively, had been previously identified (12-14). The genome of X. 
nematophila contains four additional NRPS gene clusters, referred to as clusters A, C, E 
and F. The compounds synthesized by these clusters have not yet been identified 
(TABLE 4). To determine whether the additional gene clusters produced antimicrobial 
compounds the first NRPS gene of each cluster was inactivated. We also inactivated the 
first NRPS gene in the PAX and the rhabdopeptide clusters In addition, the ngrA gene 
that encodes the phosphopantetheinyl transferase required for activity of NRPS and PKS 
enzymes was inactivated. The antibiotic activity of the individual mutant strains was 
analyzed in an overlay assay using M. luteus as the indicator strain. Antibiotic activity 
was not detectably reduced in any of the NRPS mutant strains (data not shown). As 
expected, antibiotic production was completely eliminated in the ngrA strain (FIG. 3.2). 
Since antimicrobials produced by the NRPS gene clusters may be masked by the high 
level of xenocoumacin detected in the overlay assay we created double mutant strains in a 
xenocoumacin-deficient background in which xcnK and part of xcnL were deleted 
(ΔxcnKL strain). The antibiotic activity of the ΔxcnKL strain was reduced but not 
eliminated as shown previously with the xcnA strain (FIG. 3.2). Inactivation of the first  
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FIG. 3.2. Antibiotic overlay assay demonstrating activity of xenocoumacin against 
M.luteus, E. faecalis and S. saprophyticus; of compound F against M. luteus and S. 
saprophyticus; and complete lack of activity of the ngrA mutant. Antibiotic overlay 
assays were performed with X. nematophila wild-type and mutant strains (ΔxcnKL, 
ΔxcnKL:F, ngrA) against the common indicator organism M. luteus and relevant 
competitors isolated from the insect host gut: S. saprophyticus and E. faecalis. The 
diameter of the zone of inhibition is proportional to the sensitivity of the competitors to 
X. nematophila antibiotics.   
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NRPS gene in cluster F in the ΔxcnKL background resulted in almost complete loss of a 
zone of inhibition indicating that compound F possessed antibiotic activity against M. 
luteus. The ΔxcnKL:C strain also displayed a markedly reduced zone of inhibition 
indicating that cluster C also possessed antimicrobial activity (FIG. 3.3).  For the other 
double mutant strains the zone of inhibition was the same as that for the ΔxcnKL strain 
indicating that these clusters did not produce antibiotic activity against M. luteus.  
 We had previously isolated Staphylococcus saprophyticus and Enterococcus 
faecalis strains from the gut of Manduca sexta and showed these microbes translocate 
into the hemocoel during nematode invasion (28). In overlay assays, S. saprophyticus 
was highly sensitive to X. nematophila antibiotics while E. faecalis was more resistant. 
We used these biologically relevant isolates to assess the antibiotic activity of the 
ΔxcnKL and ΔxcnKL:F strains. The antibiotic activity of the ΔxcnKL strain was 
significantly reduced against S. saprophyticus and was undetectable in the assay against 
E. faecalis (FIG. 3.2). Antibiotic activity against S. saprophyticus was further reduced in 
the ΔxcnKL:F strain and completely lost in the ngrA strain (FIG. 3.2). These findings 
show that xenocoumacin is active against both the biologically relevant competitors S. 
saprophyticus and E. faecalis, and it is the major antibiotic activity against E. faecalis. 
Compound F was shown to possess activity against S. saprophyticus. The ΔxcnKL, F, 
ΔxcnKL:F, and ngrA mutant strains were used for further analysis.  
 
3.2.2. Competition of S. saprophyticus and E. faecalis with X. nematophila 
 The above results suggested that xenocoumacin and compound F are active 
against microbial competitors that enter the hemocoel during early stage infection. Since 
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FIG. 3.3. Antibiotic overlay assay demonstrating antibiotic activity of compound C and lack of activity of compounds A, B, D 
and E. Antibiotic overlay assays were performed with X. nematophila wild-type and mutant strains (ΔxcnKL, ΔxcnKL:A, ΔxcnKL:B, 
ΔxcnKL:C, ΔxcnKL:D, ΔxcnKL:E) against the common indicator organism M. luteus. The diameter of the zone of inhibition is 
proportional to the sensitivity of the competitors to X. nematophila antibiotics.  
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xenocoumacin has been shown to be produced in nutrient-rich medium (LB broth), 
competition experiments were first performed between wild-type and mutant strains of X. 
nematophila and either S. saprophyticus or E. faecalis in LB broth (FIGS. 3.4 and 3.5). 
Exponentially growing X. nematophila and competitor cultures were co-inoculated in a 
1:1 ratio and grown for 24 h. Culture samples were dilutionally plated at 9 h, 18 h and 24 
h to determine the relative cell density of the respective strains. By 9 h the cell density of 
the X. nematophila strains and S. saprophyticus had increased over 100-fold (FIG. 3.4). 
The ratio of S. saprophyticus to X. nematophila was higher in the ΔxcnKL, ΔxcnKL:F and 
ngrA co-cultures. At 18 h the cell density of S. saprophyticus was significantly reduced in 
co-cultures with the wild-type and F
 
strain, while the S. saprophyticus was eliminated by 
24 h. In contrast, the levels of S. saprophyticus remained high at 24 h in co-cultures with 
the ΔxcnKL and ΔxcnKL:F strains and was significantly higher in the ngrA strain. These 
results indicated that xenocoumacin but not compound F was required to eliminate S. 
saprophyticus in LB broth co-cultures.  
 Co-culture competition experiments were also carried out with E. faecalis (FIG. 
3.5). At 9 h the cell density of all X. nematophila strains except the ngrA strain was 
higher than the level of E. faecalis. At 18 h and 24 h E. faecalis was eliminated in all co-
cultures except for those with the ngrA strain. These findings indicate that neither 
xenocoumacin nor compound F were required to eliminate E. faecalis, and that other 
NRPS-derived compounds were active against this competitor.  
To more closely mimic the biological conditions that occur during natural 
infection, competition experiments were performed in Grace’s medium, a defined 
medium based on lepidopteran hemolymph (FIG. 3.6). In co-cultures with S. 
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FIG. 3.4. In vitro competition between X. nematophila mutant strains and S. saprophyticus in LB. Subcultures of X. nematophila 
wild-type and mutant strains (ΔxcnKL, F, ΔxcnKL:F, ngrA) (dark gray bars) were mixed in a 1:1 ratio with S. saprophyticus (white 
hatched bars) and then used to inoculate fresh LB broth. Competition outcome was determined by dilution plating 0 (A), 9 (B), 18 (C), 
and 24 h (D). Graphs depict colony forming units/ml (CFU/ml) of both bacteria. Asterisks depict statistically significant differences 
(P<0.05) as calculated by multiple paired t-tests using GraphPad Prism 6. 
 
 
 
 
 
 
 
 
 
8
4
 
 
 
 
 
FIG. 3.5. In vitro competition between X. nematophila mutant strains and E. faecalis in LB. Subcultures of X. nematophila wild-
type and mutant strains (ΔxcnKL, F, ΔxcnKL:F, ngrA) (dark gray bars) were mixed in a 1:1 ratio with E. faecalis (light gray bars) and 
then used to inoculate fresh LB broth. Competition outcome was determined by dilution plating at 0 (A), 9 (B), 18 (C), and 24 h (D). 
Graphs depict colony forming units/ml (CFU/ml) of both bacteria. Asterisks depict statistically significant differences (P<0.05) as 
calculated by multiple paired t-tests using GraphPad Prism 6. 
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FIG. 3.6. In vitro competition of wild-type X. nematophila with S. saprophyticus (A) 
or E. faecalis (B) in Grace’s. Subcultures of wild-type X. nematophila were mixed in a 
1:1 ratio with either S. saprophyticus (white hatched bars) or E. faecalis (light gray bars) 
and then used to inoculate fresh Grace’s media. Competition outcome was determined by 
dilution plating at times 0, 9, 24, and 48 h. Graphs depict colony forming units/ml 
(CFU/ml) of both bacteria. No statistically significant differences between X. 
nematophila and the competitors were found at any of the time points. 
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saprophyticus the cell density of wild-type X. nematophila at 9 h was ~5.8x10
8 
CFU/ml, 
in contrast to the ~10-fold higher level that was reached in LB broth. Unlike in the co-
cultures in LB broth the cell density of S. saprophyticus was actually higher than X. 
nematophila at 24 h and remained at high levels at 48 h (FIG. 3.6.A). The same results 
were obtained in co-cultures with E. faecalis (FIG. 3.6.B).  Thus, in Grace’s medium the 
cell density of wild-type X. nematophila was ~10-fold less than the level reached in LB 
broth and the amount of antimicrobials produced were not sufficient to eliminate either S. 
saprophyticus or E. faecalis. In addition, we found that when grown individually both S. 
saprophyticus and E. faecalis grew much faster than X. nematophila in Grace’s medium 
during early growth phase. At 6 h the cell density of S. saprophyticus and E. faecalis was 
~ 8-fold and 105-fold greater, respectively, than X. nematophila (TABLES 7 and 8). 
 
3.2.3. Comparison of antibiotic activity in LB broth and Grace’s medium culture 
supernatants  
 To compare the relative levels of antibiotic activity produced by wild-type X. 
nematophila grown in LB broth and Grace’s medium, sterile cell-free supernatants 
prepared from cultures grown for 6 h, 9 h and 12 h were assayed in a microplate format 
using S. saprophyticus as the indicator strain (TABLE 9). Results were expressed as % 
inhibition of growth comparing the cell density (measured as optical density, O.D600) of 
the treated culture with the untreated culture of S. saprophyticus. At 6 h antibiotic activity 
was detectable at low and variable levels with either LB broth or Grace’s medium 
supernatants.  At 9 h the undiluted LB broth supernatants displayed 90% growth 
inhibition while the 0.5X diluted sample gave 34% growth inhibition. At 12 h the 
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                           TABLE 7. Growth comparison between X. nematophila and S. saprophyticus in Grace’s medium 
 
 
 
 
 
 
 
 
 
 
 
 
                                      a 
CFU/ml relative to that at 0 h
  
 X. nematophila  S. saprophyticus     S. sapro/X. nem 
     
Time (h) CFU/ml x 10
8 
Fold increase 
a 
CFU/ml x 10
8 
Fold increase 
a 
Fold increase 
      
      
0   0.12 (0.01)     -   0.28 (0.01)      -   - 
6   2.88 (0.50)   24.00 53.70 (11.29) 191.79 7.99 
9 19.65 (2.69) 163.75 93.90 (23.74) 335.36 2.05 
12 15.87 (4.03) 132.25 59.13 (11.14) 211.18 1.60 
24   9.28 (0.48)   77.33 23.35 (2.65)   83.39 1.08 
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                     TABLE 8. Growth comparison between X. nematophila and E. faecalis in Grace’s medium 
 
 
 
 
 
 
 
 
 
 
 
 
                             a 
CFU/ml relative to that at 0 h 
 
 
 
 X. nematophila  E. faecalis     E. faec/X. nem 
     
Time (h) CFU/ml x 10
7 
Fold increase 
a 
   CFU/ml x 10
8 
    Fold increase 
a 
  Fold increase 
      
      
0    0.11 (0.03)     - 0.11 (0.02)        -      - 
6    7.10 (1.35)   64.55 746.25 (136.55) 6784.09        105.10 
9  78.43 (13.95) 713.00 1291.93 (598.31)      11744.82  16.47 
12  87.70 (6.82) 797.27   543.13(90.22) 4937.55    6.19 
24  53.38 (12.75) 485.27     30.90 (3.17)   280.91    0.58 
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TABLE 9. X. nematophila antibiotic activity in cell-free supernatants 
 
  
 Time (h)            % Inhibition 
  1X 0.5X 
LB broth 6 10.3 (3.7)   8.4 (3.3) 
9 89.9 (3.8) 33.5 (2.2) 
12 96.3 (0.7) 84.0 (2.3) 
    
Grace’s medium 6 10.2 (1.3) 14.1 (1.1) 
9 20.1 (0.6)   7.8 (3.7) 
12 96.9 (0.6)   4.2 (2.2) 
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antibiotic activity had increased in the LB broth supernatants, and was present at high 
levels in both undiluted and diluted supernatants. In contrast, the antibiotic activity in the 
supernatant from Grace’s medium was barely detectable at 9 h. At 12 h the undiluted 
supernatants from Grace’s medium displayed   ~ 97% growth inhibition while little 
activity was present in the diluted supernatants. The low level of production in Grace’s 
medium correlated with lower cell density relative to the LB broth levels (FIG. 3.7).  
These findings show that antibiotics were produced later and at lower levels in Grace’s 
medium as compared to LB broth cultures.  
 
3.2.4. Competition in Grace’s medium pre-inocubated with X. nematophila strains 
 The combination of low level antibiotic production by X. nematophila and more 
rapid initial growth rates of S. saprophyticus and E. faecalis in Grace’s medium resulted 
in the inability of X. nematophila to suppress growth of microbial competitors. To further 
assess the role of antimicrobial production in interspecies competition, wild-type and 
mutant strains of X. nematophila were first inoculated in Grace’s medium and grown for 
10.5 or 11.5 h before inoculating with either S. saprophyticus or E. faecalis. The co-
cultures were dilutionally plated at 24 h to determine the cell density of the respective 
strains (TABLES 10 and 11). S. saprophyticus was eliminated in co-cultures with the 
wild-type and NRPS mutant strains but grew to high levels in co-culture with the ngrA 
strain. These findings indicate that NRPS-derived antibiotics other than xenocoumacin 
and compound F were required to eliminate S. saprophyticus in Grace’s medium. In 
contrast, E. faecalis was not eliminated when co-cultured with any of the pre-inoculated 
X. nematophila strains. The relative resistance of E. faecalis to X. nematophila antibiotics 
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FIG. 3.7. Temporal cell density of X. nematophila in LB broth and Grace’s medium
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                       TABLE 10. Competition of S. saprophyticus with pre-incubated X. nematophila in Grace’s medium 
 
 X. nematophila  S. saprophyticus  
                       Initial cell density 
a 
 
Strains CFU/ml x 10
8  b
 CFU/ml x 10
8
 
WT 25.5 (3.0) 1.1 (0.1) 
ΔxcnKL 21.7 (2.1) 1.1 (0.1) 
F
 
31.9 (4.4) 1.1 (0.1) 
ΔxcnKL:F 32.7 (3.2) 1.1 (0.1) 
ngrA
 
34.9 (4.7) 1.1 (0.1) 
   
                  Cell density after 24 h 
c
 
WT 7.9 (1.7) 0.0  
ΔxcnKL 3.9 (0.8) 0.0  
F
 
3.9 (0.4) 0.0  
ΔxcnKL:F 1.4 (0.3) 0.0  
ngrA
 
6.9 (0.9) 3.8 (0.6) 
                                    a 
Cell density at start of competition after X. nematophila was pre-incubated for 10.5 h 
                                    b 
Values represent mean and standard error (parentheses) 
                                    c 
Cell density after 
 
24 h of competition 
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     TABLE 11. Competition of E. faecalis with pre-incubated X. nematophila in Grace’s medium 
 
 X. nematophila  E. faecalis  
                       Initial cell density 
a 
 
Strains CFU/ml x 10
8  b
 CFU/ml x 10
8
 
WT 14.3 (1.2) 0.7 (0.0) 
ΔxcnKL 13.9 (1.4) 0.7 (0.0) 
F
 
45.5 (5.3) 0.7 (0.0) 
ΔxcnKL:F 26.4 (2.2) 0.7 (0.0) 
ngrA
 
31.6 (2.8) 0.7 (0.0) 
   
                  Cell density after 24 h 
c
 
WT   9.1 (0.9) 0.7 (0.3) 
ΔxcnKL   5.6 (0.4) 0.1 (0.0) 
F
 
19.3 (1.3) 0.9 (0.1) 
ΔxcnKL:F   3.0 (0.5) 0.4 (0.0) 
ngrA
 
18.7 (2.8) 2.1 (0.4) 
                                           a 
Cell density at start of competition after X. nematophila was pre-incubated for 11.5 h 
                                           b 
Values represent mean and standard error (parentheses) 
                                           c 
Cell density after 
 
24 h of competition 
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and the lower level of antibiotic production by X. nematophila in Grace’s medium 
apparently accounts for the inability to eliminate this competitor. 
 
3.2.5. Competition in the insect host, Manduca sexta 
 We had previously shown that when S. saprophyticus was injected into M. sexta it 
was present in the hemolymph at low levels (~10
2 
CFU/ml) at 9 h and grew to slightly 
higher cell density (~10
3 
CFU/ml) at 24 h (28). However, when S. saprophyticus was co-
injected with wild-type X. nematophila it was eliminated by 24 h. This finding, together 
with the sensitivity of S. saprophyticus to X. nematophila antibiotics, suggested that 
antibiotic production could be involved in the elimination of S. saprophyticus in vivo. To 
address this question S. saprophyticus was co-injected into the hemocoel of M. sexta with 
either the ΔxcnKL (FIG. 3.8) or the ngrA strain (FIG. 3.9) and hemolymph was collected 
and dilutionally plated at 8 h and 24 h post-injection. In both cases S. saprophyticus was 
present at 8 h and was eliminated by 24 h. This finding suggests that NRPS-derived 
antibiotics were not essential for elimination of S.  saprophyticus in vivo. In contrast, E. 
faecalis growth was shown to be facilitated when co-injected with wild-type X. 
nematophila (28) and also was facilitated when co-injected with either the ΔxcnKL (FIG. 
3.8) or ngrA (FIG. 3.9) strain.   
 
3.2.6. Natural infection and nematode reproduction in M. sexta 
 It has been proposed that sub-inhibitory concentrations of antibiotics and other 
secondary metabolites can function as signaling molecules (22-24, 34, 35). With this in 
mind we addressed the possibility that NRPS-derived compounds produced by X. 
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FIG. 3.8. In vivo growth after 1:1 co-injections of X. nematophila ΔxcnKL strain with 
S. saprophyticus or E. faecalis into M. sexta. Insects were co-injected with a 1:1 mixture 
of X. nematophila ΔxcnKL (dark gray bars) with either S. saprophyticus (white hatched 
bars) or E. faecalis (light gray bars). 10
4 
CFU/insect of each strain were injected. 
Hemolymph recovered at 8 and 24 h post-injection was dilutionally plated. Data are 
represented as CFU/ml of each bacterial species at 8 and 24 h. Asterisks depict 
statistically significant differences (P<0.05) as calculated by multiple paired t-tests using 
GraphPad Prism 6. 
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FIG. 3.9. In vivo growth after 1:1 co-injections of X. nematophila ngrA strain with S. 
saprophyticus or E. faecalis into M. sexta. Insects were co-injected with a 1:1 mixture 
of X. nematophila ngrA (dark gray bars) with either S. saprophyticus (white hatched bars) 
or E. faecalis (light gray bars). 10
4 
CFU/insect of each strain were injected. Hemolymph 
recovered at 8 and 24 h post-injection was dilutionally plated. Data are represented as 
CFU/ml of each bacterial species at 8 and 24 h. Asterisks depict statistically significant 
differences (P<0.05) as calculated by multiple paired t-tests using GraphPad Prism 6. 
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nematophila might play a role in in vivo reproduction of the nematode, S. carpocapsae. 
To assess this possibility, IJs harboring either the wild-type or ngrA strain of X. 
nematophila were used for natural infections of M. sexta. When the insects died 24-48 h 
post-injection the cadavers were transferred to water traps and the cumulative number of 
emergent progeny IJs was monitored over a 27 day period (FIG. 3.10). When infected 
with wild-type X. nematophila - carrying nematodes, progeny IJs began to appear in the 
water traps at day 11 and continued to accumulate for 25 days reaching a level of 7300 
IJs/ml.  In contrast, when infected with IJs colonized with the ngrA strain, progeny IJs 
appeared in much lower numbers and after 25 days only 1947 IJs/ml had accumulated in 
the water traps. In contrast, nematodes reproduced to a similar extent on lawns of wild 
type and ngrA strains (data not shown) suggesting that the ngrA strain was not defective 
in providing a nutrient base for nematode reproduction. The ngrA strain also grew as well 
as the wild type strain when injected into M. sexta (FIG. 3.9). Together, these findings 
suggest that NRPS-derived compounds are involved in stimulating optimal nematode 
reproduction and emergence in vivo.   
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FIG. 3.10. In vivo nematode reproduction using S. carpocapsae carrying X. 
nematophila wild-type and ngrA strains after natural infection of M. sexta. The total 
number of IJs emerging from insect cadavers infected with S. sarpocasae harboring 
either wild-type (dark gray bars) or ngrA (light gray bars) X. nematophila strains were 
counted for a period of 27 days from the day of trapping. Three traps containing four 
insects each were used for both sets and IJs were counted in five 5 µl drops (n = 15). 
Except for the initial time point (Day 11), the mean values for the wild type and the 
mutant were significantly different at each time point (two-tailed P<0.01); when paired at 
each time point (including Day 11), the wild type and the mutant were also significantly 
different over the entire time scale examined (paired two-tailed P<0.001). Error bars 
represent standard errors. 
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3.3. Discussion 
 We showed previously that insect gut microbes translocate into the hemocoel 
during nematode invasion. Transient species such as S. saprophyticus disappeared early 
while persistent species such as E. faecalis proliferated in the presence of X. nematophila. 
In the present study we examined the possible role of NRPS-derived antimicrobials in 
early stages of interspecies competition. X. nematophila possesses seven NRPS-
containing gene clusters and two large stand alone NRPS genes. Transfer of a 
phosphopantetheinyl group to the PCP domain by PPant transferase encoded by ngrA is 
required for NRPS function. Using NRPS and ngrA mutant strains and an overlay 
diffusion assay we found that xenocoumacin and an uncharacterized antimicrobial, 
compound F, accounted for most of the antimicrobial activity against S. saprophyticus. 
Xenocoumacin, a hydrophilic benzopyran compound, was shown previously to be active 
against S. aureus and Streptococcus species (7). The present study is the first to show that 
xenocoumacin is active against a potential competitor derived from the gut of an insect 
host. As predicted from previous results E. faecalis was relatively resistant to X. 
nematophila antibiotics.  
Most of the X. nematophila antimicrobials and secondary metabolites 
characterized to date are hydrophobic. Since the overlay assay detects compounds that 
diffuse away from a bacterial colony grown on LB agar more hydrophobic compounds 
may exhibit limited activity in this assay. For this reason a liquid medium-based 
competition assay in which antibiotics disperse throughout the culture was used to 
examine the role of NRPS-derived compounds in interspecies competition. Wild-type and 
NRPS mutant strains were co-inoculated in LB broth with either S. saprophyticus or E. 
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faecalis and cultures were continually shaken during the assay. S. saprophyticus was not 
eliminated in co-cultures with either the ΔxcnKL or ΔxcnKL:F strains but was eliminated 
in co-cultures with the wild-type and F strains indicating that  xenocoumacin was 
required to eliminate S. saprophyticus. In contrast, E. faecalis was eliminated in co-
cultures with the ΔxcnKL and ΔxcnKL:F strains but not the ngrA strain indicating that 
NRPS-derived antibiotics other than xenocoumacin and compound F were produced at 
levels sufficient to eliminate E. faecalis.  
To assess the contribution of antimicrobials under more natural biological 
conditions co-culture competition experiments were performed in Grace’s insect medium. 
Under these conditions neither S. saprophyticus nor E. faecalis were eliminated 
suggesting that antimicrobials were produced at sub-inhibitory levels. Indeed, antibiotic 
activity in sterile cell-free supernatants from X. nematophila grown in Grace’s medium 
was markedly lower than supernatants for cells grown in LB broth. Importantly, the cell 
density of the Grace’s medium cultures was ~10-fold lower than in LB broth. In many 
microbial species studied robust antibiotic production involves quorum sensing in which 
accumulation of autoinducer molecules at higher cell densities activate the expression of 
secondary metabolite genes (22). The lower cell density and autoinducer concentrations 
in cultures in Grace’s medium could result in reduced levels of antibiotic production and 
the inability to eliminate competitors. In addition, secondary metabolite production was 
induced by the addition of 50 mM L-proline to cultures of X. nematophila (36). Grace’s 
medium contains only 3 mM L-proline. We found that addition of 50mM L-proline to 
Grace’s cultures did not stimulate antibiotic production (unpublished data) suggesting 
that other environmental and metabolic signals may be involved in inducing NRPS genes 
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in X. nematophila in Grace’s medium. In well studied antibiotic producers such as 
Streptomyces coelicolor numerous regulatory cascades and metabolic signals control 
antibiotic production (37). Taken together, the lower cell density of X. nematophila and 
possible suboptimal inducing conditions could account for the inability to eliminate 
competitors in Grace’s medium.  
We also found that the cell density of S. saprophyticus in Grace’s medium 
increased 8-fold faster than X. nematophila at 6 h post-inoculation. Thus, competitor cell 
densities reached high levels before antibiotics have time to accumulate. To be able to 
detect antimicrobial activity in Grace’s medium X. nematophila was first grown for ~10 h 
and S. saprophyticus was subsequently inoculated into the culture. Under these 
conditions S. saprophyticus was eliminated by the wild-type and NRPS strains but not the 
ngrA strain indicating that NRPS-derived antimicrobial besides xenocoumacin and 
compound F were able to inhibit growth of S. saprophyticus. Thus, detection of 
antimicrobial activity against S. saprophyticus was dependent on the type of assay 
employed.  Xenocoumacin and compound F were detected in the overlay assay, 
xenocoumacin but not compound F in the LB competition assay and NRPS-derived 
antimicrobial activity besides xenocoumacin and compound F in the Grace’s medium 
assay.  Elucidation of the environmental and metabolic signals that control NRPS gene 
expression would shed light on the role of antimicrobial activity in interspecies 
competition in different host insects. 
 We showed previously that S. saprophyticus persisted when injected alone into M. 
sexta, proliferated when co-injected with E. faecalis and was eliminated when co-injected 
with X. nematophila. Here we show that co-injection with either the ΔxcnKL or ngrA 
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strains resulted in disappearance of S. saprophyticus. Thus, antimicrobial agents other 
than NRPS-derived compounds may be involved in the elimination of S. saprophyticus 
and presumably other transient species. X. nematophila produces indole derived 
compounds that are highly active against B. cereus and M. luteus (20), nematophin that is 
active against S. aureus strains (21) and benzylideneacetone that possesses both 
antimicrobial and immunosuppressive activities and is active against Gram-negative plant 
pathogens (18).  X. nematophila may also produce additional as yet unidentified 
compounds that are active against transient species. Since gut microbiota may vary 
widely in different insect hosts the potential to synthesize a spectrum of antimicrobial 
compounds that are active against a variety of microbes confers competitive advantages 
in diverse host environments. 
 It remains unknown whether during early stages of infection X. nematophila 
produces antimicrobials at levels that can inhibit species growing in the hemolymph of 
M. sexta. Using an in-vivo expression technology approach NRPS genes encoding 
rhabdopeptide that possesses anti-parasite activity were shown to be expressed soon after 
X. nematophila was injected into M. sexta (14). Induction of other NRPS genes that 
encode known antimicrobial compounds was not detected by this approach. As discussed 
above, L-proline induces secondary metabolite synthesis in X. nematophila (36). The L-
proline concentration in M. sexta is low (3 mM) relative to that in other lepidopterans 
such as Galleria mellonella (72 mM). Furthermore, X. nematophila was barely detectable 
at early stages of natural infection unlike the higher levels present when co-injected with 
S. saprophyticus (FIGS. 3.8 and 3.9). Thus, elimination of transient species during early 
stages of natural infection may be due initially to activation of immune responses. As X. 
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nematophila proliferates with concomitant suppression of immune responses increased 
antimicrobial levels could effectively inhibit growth of transient competitors. 
Presumably, when X. nematophila reaches higher cell density during later stages of 
infection elevated levels of antimicrobials prevent the reemergence of transient species.   
 The scenario for interactions between X. nematophila and a persistent species 
such as E. faecalis is distinctly different. E. faecalis is relatively resistant to 
xenocoumacin but is sensitive to other yet identified antimicrobials produced by X. 
nematophila grown in LB broth. In contrast, antimicrobial activity produced in Grace’s 
medium was insufficient to eliminate E. faecalis. In addition, the increase in cell density 
of E. faecalis inoculated into Grace’s was 105-fold greater than X. nematophila 6 h post-
inoculation. Furthermore, rather than being eliminated, E. faecalis growth was facilitated 
by the presence of X. nematophila in vivo. We had shown that E. faecalis strongly 
induced cecropin transcription in M. sexta while transcript levels were reduced markedly 
when E. faecalis was co-injected with X. nematophila. Together, these findings suggest 
that the dominance and persistence of E. faecalis during natural infection could result 
from the combination of rapid growth rate after translocation into the insect hemolymph, 
relative resistance to antimicrobials produced in the hemolymph and suppression of the 
host immune response by X. nematophila. 
 Bacterial factors that influence S. carpocapsae growth and development in vivo 
had not been previously studied. Here we show that reproduction of nematodes in M. 
sexta naturally infected with IJs colonized with the ngrA strain was dramatically reduced 
relative to levels obtained with the wild-type strain.  It was shown previously that 
nematodes reared on lawns of an lrp strain in which numerous phenotypic traits were lost 
104         
 
 
reproduced to a lesser extent than those raised on the wild-type lawns (38). The number 
of IJ progeny that emerged from the lrp lawns was ~85% of the number obtained with the 
wild-type strain. In P. luminescens inactivation of ngrA resulted in loss of antibiotic and 
siderophore production while other phenotypic traits examined were similar to the wild-
type strain (27). The development of Heterorhabditis bacteriophora IJs to the J4 stage 
was significantly reduced when grown on lawns of the ngrA strain. Moreover, nematodes 
were unable to reproduce on the ngrA strain. Since a siderophore mutant was able to 
support nematode reproduction (39) it was concluded that the ngrA gene is involved in 
production of a signaling compound for nematode development. Likewise, recovery of H. 
bacteriophora IJs on a P. luminescens strain that was deficient in production of 
multipotent stilbene compounds was significantly reduced relative to that of nematodes 
grown on lawns of wild-type cells (40). Thus, in P. luminescens both ngrA-derived 
compounds and stilbenes are required for nematode reproduction in vitro. Whether these 
compounds are involved in growth and development in vivo remains to be determined. To 
our knowledge the findings of the present study with the ngrA strain are the first to 
establish a role for bacterial products for S. carpocapsae growth and development in an 
insect host.  
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Appendix 
Supplemental Figures: Structures of Compounds Produced by X. 
nematophila and Schematic Illustrations of NRPSs 
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FIG. A.1. Known antimicrobial compounds produced by X. nematophila. (Sources: 
Xenocoumacin - McInerney BV, Taylor WC, Lacey MJ, Akhurst RJ, Gregson RP. 1991. 
Biologically active metabolites from Xenorhabdus spp., Part 2. Benzopyran-1-one 
derivatives with gastroprotective activity. J. Nat. Prod. 54:785-795; xenematide and 
xenortide - Lang G, Kalvelage T, Peters A, Wiese J, Imhoff JF. 2008. Linear and cyclic 
peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. J. Nat. Prod. 
71:1074-1077; PAX - Fuchs SW, Proschak A, Jaskolla TW, Karas M, Bode HB. 2011. 
Structure elucidation and biosynthesis of lysine-rich cyclic peptides in Xenorhabdus 
nematophila. Org. Biomol. Chem. 9:3130-3132; rhabdopeptide - Reimer D, Cowles 
KN, Proschak A, Nollmann FI, Dowling AJ, Kaiser M, Constant Rf, Goodrich-Blair H, 
Bode HB. 2013. Rhabdopeptides as insect-specific virulence factors from 
entomopathogenic bacteria. Chembiochem. 14:1991-1997)  
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FIG. A.2. Other small molecules produced by X. nematophila with antibiotic 
activity. (Sources: Indole derivatives – Paul VJ, Frautschy S, Fenical W, Nealson KH. 
1981. Antibiotics in microbial ecology, isolation and structure assignment of several new 
antibacterial compounds from the insect-symbiotic bacteria Xenorhabdus spp. J. Chem. 
Ecol. 7:589-597 and Sundar L, Chang FN. 1993. Antimicrobial activity and biosynthesis 
of indole antibiotics produced by Xenorhabdus nematophilus. J. Gen. Microbiol. 
139:3139-3148; nematophin - Li J, Chen G, Webster JM. 1997. Nematophin, a novel 
antimicrobial substance produced by Xenorhabdus nematophilus (Enterobactereaceae). 
Can. J. Microbiol. 43:770-773; benzylideneacetone - Ji D, Yi Y, Kang GH, Choi YH, 
Kim P, Baek NI, Kim Y. 2004. Identification of an antibacterial compound, 
benzylideneacetone, from Xenorhabdus nematophila against major plant-pathogenic 
bacteria. FEMS Microbiol. Lett. 239:241-248) 
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FIG. A.3. Reactions catalyzed by NRPS domains. (A) The A domain recognizes and 
activates a dedicated amino acid, (B) the activated aminoacyl adenylate covalently 
attaches onto the free thiol group of the PCP-bound Ppant cofactor, (C) the C domain 
carries out peptide elongation by catalyzing an attack of the nucleophilic amine of the 
acceptor substrate onto the electrophilic thioester of the donor substrate. (Source: Sieber 
SA, Marahiel MA. 2005. Molecular mechanisms underlying nonribosomal peptide 
synthesis: approaches to new antibiotics. Chem. Rev. 105:715-738) 
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FIG. A.4. Phosphopantetheinylation by the enzyme PPTase which is a product of 
the ngrA gene in X. nematophila. The phosphopantetheine moiety of coenzyme A is 
covalently attached to the PCP domain by PPTase, a dedicated phosphopantetheinyl 
transferase. (Adapted from: Sieber SA, Marahiel MA. 2005. Molecular mechanisms 
underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem. Rev. 
105:715-738) 
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